Characterization and function studies of Ncr1p: A yeast ortholog of mammalian niemann pick C1 protein (NPC1) by ZHANG SHAO CHONG
CHARACTERIZATION AND FUNCTION STUDIES OF 
Ncr1p: A YEAST ORTHOLOG OF MAMMALIAN 






(B.S. WUHAN UNIV.) 








A THESIS SUBMITTED  
FOR THE DEGREE OF DOCTOR OF PHYLOSOPHY 
DEPARTMENT OF BIOCHEMISTRY 




                                                                                   - 1 - 
Acknowledgement 
 
This thesis is the main part of research work done for four and half years 
whereby many people have helped and supported me during this period. It’s my 
pleasure to formally express my gratitude to all of them. 
Firstly, I would like to thank my mentor, Dr. Hongyuan Yang for his dedicated 
supervision since January, 2001. His overly enthusiasm and active thinking on science 
has made a deep impression on me. I sincerely thank him for showing me the way of 
research. It is difficult to estimate how much I have learned from him. Therefore, I am 
really glad to know Dr. Yang in my life. 
My colleagues in Dr. Yang’s lab gave me the harmonious feeling of being at 
home at work. They are Woo Wee Hong, Jaspal Kaur Kumar, Zhang Qian, Ren Jihui, 
Li Hongzhe, Lai Liyun, Low Soo Mei, Liew Li Phing, Fei Weihua, Zheng Li, Ho Zi 
Zong, Chieu Hai Kee, Low Choon Pei, and Wang Peng Hua. At the same time, I am 
extremely happy to be part of you all. I greatly appreciate Dr. Zhang Qian for taking 
care of my studies and living in Singapore with tremendous energy. I also especially 
thank Dr. Jaspal Kaur Kumar for revising this thesis with terrible patience. 
I am grateful to Dr. Alan Munn for his help to study sucrose density gradient 
centrifugation techniques. I also thank Dr. Liang Fubo from Professor Chang’s Lab 
who helped me to learn SDS-PAGE electrophoresis of membrane proteins. It was my 
pleasure to work with them and the students and employees from their labs. 
Deeply from my heart, I would like to thank my wife for her love and support, 
                                                                                   - 2 - 
even at the most difficult time, I was happy and peaceful. It is a pleasure to share my 
happiness and sorrows with her.  
With the support of all of them part of our results have been published in Traffic 



















                                                                                   - 3 - 
Table of Contents 
Acknowledgement .........................................................................................................2 
Table of Contents ...........................................................................................................4 
Summary ......................................................................................................................10 
List of Tables................................................................................................................12 
List of Figures ..............................................................................................................13 
Abbreviations and Symbols Used................................................................................15 
Chapter 1 Introduction .................................................................................................20 
1.1 Biochemistry of Cholesterol...............................................................................20 
1.1.1 Chemical Structure of Cholesterol...............................................................20 
1.1.2 The Features and Functions of Cholesterol .................................................23 
1.1.3 Biosynthesis of Cholesterol .........................................................................26 
1.1.4 Cholesterol Metabolism...............................................................................26 
1.2 Intracellular Cholesterol Homeostasis................................................................29 
1.2.1 Introduction to Cholesterol Homeostasis.....................................................29 
1.2.2 A Key Domain and Protein Involved in Intracellular Cholesterol 
Homeostasis ..........................................................................................................32 
1.2.2.1. Sterol-sensing Domain (SSD) Proteins ................................................33 
1.2.2.2 Oxysterol and OSBP .............................................................................34 
1.2.3 The Role of Cholesterol Metabolism, Esterification and 
Cholesterol Transport in Cholesterol Homeostasis...............................................36 
1.2.3.1 Regulation of HMG-CoA Reductase.....................................................37 
                                                                                   - 4 - 
1.2.3.2 The Activation of SREBPs ....................................................................39 
1.2.3.3 The Cholesterol Esterification Enzyme: ACAT ....................................42 
1.2.3.4 Cholesterol Transport through the PM ..................................................44 
1.2.3.6 Intracellular Cholesterol Transport........................................................51 
1.3 A Putative Cholesterol Transporter, NPC1.........................................................60 
1.3.1 Molecular and Cell Biology of NPC1..........................................................60 
1.3.2 The Pathogenicityof NPC Disease...............................................................62 
1.3.3. The Gene and Localization of NPC1 Protein .............................................63 
1.3.4. The Topology of NPC1 ...............................................................................64 
1.3.5. Function of NPC1 .......................................................................................65 
1.3.6. The Effect of NPC1 in Brain.......................................................................69 
1.3.7 Mutant Proteins which Produce NPC-like Phenotypes ...............................70 
1.4 The Advantages of Studying Human Disease Using S. cerevisiae as a Model. .70 
1.5 Sterol Homeostasis in Yeast ...............................................................................72 
1.6 Ncr1p, the Ortholog of NPC1 in S.cerevisiae ....................................................73 
1.6 Objectives and Significance of this Study..........................................................73 
Chapter 2 Materials and Methods ................................................................................77 
2.1 Strains, Media and Materials..............................................................................77 
2.2 Production of Antisera Against Ncr1p................................................................79 
2.2.1 Expression of an 189 aa Ncr1p Polypeptide ................................................79 
2.2.2 Purification of 189aa Ncr1p Peptides Using Talon® Beads........................79 
2.2.3 Electro-elution to Purify the Peptide............................................................80 
                                                                                   - 5 - 
2.3 Characterization of Ncr1p ..................................................................................81 
2.3.1 Mini Yeast Chromosomal DNA Preparation................................................81 
2.3.2 Transformation of S. cerevisiae ...................................................................82 
2.3.3 Construction of Plasmids and Gene Disruption...........................................82 
2.3.4 Protein Extraction from Yeast Cells.............................................................84 
2.3.5 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) and Immunoblotting Analysis.........................................................85 
2.3.6 Visualization of Ncr1p-GFP.........................................................................85 
2.3.7 FM4-64 Internalization ................................................................................86 
2.3.8 4', 6'-Diamidino-2-phenylindole (DAPI) Staining of Nuclei.......................86 
2.3.9 Subcellular Fractionation .............................................................................87 
2.3.10 Detergent Resistant Membrane (DRM) Isolation ......................................88 
2.3.11 Sucrose Density Gradient Fractionation ....................................................88 
2.4 Functional Study.................................................................................................90 
2.4.1 In vivo Assays for Sterol Esterification .......................................................90 
2.4.1.1 Labeling and Drying..............................................................................90 
2.4.1.2 Cell Lysis and Neutral Lipid Extraction................................................90 
2.4.2 In vivo Assays for Sterol Esterification Under Acute Glucose 
Starvation Condition .............................................................................................92 
2.4.3 Acetate Incorporation Assay ........................................................................92 
2.4.4 In vitro (Microsomal) Assay of Sterol Esterification...................................93 
2.4.4.1. Isolation of Microsomes.......................................................................93 
                                                                                   - 6 - 
2.4.4.2 Reaction System....................................................................................94 
2.4.4.3 Measure of Sterol Esterification Activity ..............................................94 
2.4.5 GST Pull-down Assay:.................................................................................95 
2.4.6 β-galactosidase Assay with ONPG as Substrate in Liquid Culture .............97 
2.4.7 Isolation of Intact Vacuoles from Yeast .......................................................98 
2.4.8 Isolation of Vacuolar Lipids.......................................................................100 
Chapter 3 Localization and Transport of Ncr1p ........................................................101 
3.1 Introduction ......................................................................................................101 
3.2 Results ..............................................................................................................102 
3.2.1 Purification of Ncr1 189 aa peptide with Talon® beads.............................102 
3.2.2 Purification of the Ncr1p 189aa Peptide by Electroelution. ......................103 
3.2.3 Ncr1p Antibody Preparation and Detection of Ncr1p in S. 
cerevisiae Cells ...................................................................................................104 
3.2.4 Ncr1p is Predominantly Located in the P13 Membrane Fraction..............105 
3.2.5 Ncr1p Localizes to the Limiting Membrane of Yeast Vacuole ..................107 
3.2.6 Localization of Ncr1p-GFP........................................................................107 
3.2.7 Ncr1p is not Associated with Detergent-resistant Membranes 
(DRMs) ...............................................................................................................108 
3.2.8 Vacuolar Localization of Ncr1p is Impaired in Mutants Affecting 
Early but notLate Steps of the Secretory Pathway..............................................108 
3.2.9 Vacuolar Localization of Ncr1p is Impaired by the Defect in the 
Vacuolar Protein Sorting (VPS) Pathway and Vacuole Morphology, but 
                                                                                   - 7 - 
not in Endocytosis or ALP Pathway ...................................................................110 
3.2.10 Deletion of 11 Amino Acids at the Carboxyl Terminus of Ncr1p 
does not Perturb its Localization.........................................................................115 
3.2.11 Loss of Ncr1p does not Affect ALP Transport to the Vacuole .................115 
3.3 Discussion ........................................................................................................117 
Chapter 4 Functional Studies on Ncr1p .....................................................................123 
4.1 Introduction ......................................................................................................123 
4.2 Results ..............................................................................................................124 
4.2.1 The Effect of Ncr1p on Ergosterol Homeostasis .......................................124 
4.2.2 Two Yeast Orthologs of Insigs, Nsg1p and Nsg2p ....................................128 
4.2.3 The Localization of Nsgs-GFP ..................................................................130 
4.2.4 Interaction Between Nsgs and Hmg2p-GFP..............................................130 
4.2.5 Interaction between Ncr1p and Nsgs .........................................................132 
4.2.6 The Role of Ncr1p in the Unfolded Protein Response (UPR) 
Incluced by overloaded sterol .............................................................................134 
4.3 Disscusion ........................................................................................................137 
Chapter 5 Role of Ncr1p in Subcellular Sterol Transport in Saccharomyces 
cerevisiae....................................................................................................................143 
5.1 Introduction ......................................................................................................143 
5.2 Results ..............................................................................................................145 
5.2.1 Acute Glucose Starvation Induces Increase a Sterol Esterification. ..........145 
5.2.2 Deletion of NCR1 Decreases Sterol Eesterification in are2Δ but 
                                                                                   - 8 - 
not in are1Δ Mutant Cells During Acute Glucose Starvation. ............................146 
5.2.3 The Effect of ncr1Δ Deletion During Acute Glucose Starvation is 
Time Dependant. .................................................................................................148 
5.2.4 The Enzyme Activity of Are2p does not Change Upon Glucose 
Withdrawal..........................................................................................................150 
5.2.5 Free Sterol is Accumulated in the Vacuole of are2Δncr1Δ and 
are1Δare2Δncr1Δ. ...............................................................................................150 
5.3 Discussion ........................................................................................................155 
Chapter 6 Conclusions and Prospects ........................................................................162 













                                                                                   - 9 - 
Summary 
 
Niemann-Pick disease type C (NPC) is a neurodegenerative lipid storage 
disorder. This disease is characterized by the accumulation of free cholesterol within 
the endosomal/lysosomal system. Mutations of the NPC1 gene induce over 95% of 
NPC cases. The NPC1 protein predominantly localizes to late endosomes, and 
transiently associates with lysosomes. Although it is believed that the NPC1 protein 
modulates the transport of lipids in the endosomal system, the exact molecular 
function of NPC1 remains elusive. Ncr1p is a yeast ortholog of NPC1. Little is known 
about Ncr1p in yeast. 
 
The purposes of this study were to confirm the localization of Ncr1p and 
examine the synergistic effect of Ncr1p on ergosterol homeostasis with other proteins. 
The other important goal of this study was to identify other proteins involved in 
ergosterol transport pathways and to determine their relationship with Ncr1p. Sucrose 
density gradient centrifugation and fluorescence microscopy were used to observe the 
localization of Ncr1p. Oleate incorporation assay was performed to examine the effect 
of Ncr1p on sterol esterification. β-galactosidase assay was used to detect unfolded 
protein response (UPR) caused by loaded ergosterol in the ER. Acute glucose 
starvation provided a distinct intracellular ergosterol retranslocation condition. 
Vacuoles were purified and their content of free ergosterol was determined and 
compared with cellular ergosterol composition. 
 
The centrifugation and microscopy results showed that Ncr1p was localized on 
vacuole limiting membranes but not on detergent resistant membrane (DRM) domains. 
This protein was transported to its destination via the vacuole protein sorting (VPS) 
pathway. Biochemistry assays showed that there was no significant difference in 
ergosterol esterification, biosynthesis and total ergosterol between wild type and 
ncr1Δ cells. Therefore, this suggests that there may be a synergistic effect between 
Ncr1p and other ergosterol metabolism and transport related proteins, such as Nsgs, 
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Arv1p, Are1p and Are2p. Our results showed that, unlike Hmg2p, Ncr1p did not 
interact with Nsgs in vitro. On the other hand, β-galactosidase assays showed that 
deletion of the NCR1 gene partially eliminated UPR induced by excess ergosterol in 
the ER. The most important finding was a 30-minute delay of oleate incorporation 
into ergosteryl esters in are2Δncr1Δ cells compared with are2Δ cells, while there was 
no significant difference between are1Δ and are1Δncr1Δ cells. In addition, under the 
same growth condition, free ergosterol was found to accumulate about 50% more in 
the vacuole of are2Δncr1Δ cells than that in are2Δ cells.  
 
These data show that Ncr1p affects ergosterol homeostasis coordinately with 
Arv1p, Are1p and Are2p. Moreover, our results also indicate that Ncr1p regulates 
subcellular sterol transport out of the vacuole. These findings suggest that only part of 
ergosterol is transported from the periphery to the ER via the vacuole under normal 
condition. These data also support the ?? that Arv1p is involved in ergosterol transport. 
Interestingly, the ergosterol esterification enzymes may play key roles in ergosterol 
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Chapter 1 Introduction 
 
Cholesterol is an essential molecule in animals. It is important for an organism to 
maintain its balance (so-called cholesterol homeostasis). Intracellular cholesterol 
transport affects this balance. The defect in cholesterol transport can cause severe 
physiological problems. Our research interest is to understand a key step in 
intracellular cholesterol transport. Therefore in the following sections we briefly 
review the biochemical characteristics of cholesterol. 
 
1.1 Biochemistry of Cholesterol 
1.1.1 Chemical Structure of Cholesterol  
Cholesterol is a member of sterols. Sterols are a class of steroids, which are 
chemicals sharing common nucleus, 1, 2-cyclopentanoperhydrophenanthrene (sterane 
or gonane) (Figure 1.1 A). Sterane is a saturated tetracyclic hydrocarbon comprising 
17 carbons. It is almost planar and relatively rigid. The fused rings do not allow 
rotation around C-C bonds. According to the modification of the nucleus and diversity 
of side chains, steroids can be divided into several groups: sterols, brassinosteroids, 
bufadienolides, cardenolides, cucurbitacins, ecdysteroids, sapogenins, steroid 
alkaloids, withasteroids, bile acids and hormonal steroids (Callow and Young, 1936).  
Sterols are a group of unsaturated steroids with the skeleton of cholestane (Figure 
1.1 B). They contain a 3β-hydroxyl group which determines their hydrophilic property. 
An aliphatic side chain of 8 or more carbon atoms often attaches to sterols’ position 
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Figure 1.1 A. Sterane
Figure 1.1 B. Cholestane
HO
Figure 1.1 C. Cholesterol
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Figure 1.1 E. Lanosterol
HO
Figure 1.1 F. Ergosterol
HO
HO
Figure 1.1 D. Cycloartenol
 
Figure 1.1 Sterane and its derivatives. A. Sterane. B. Cholestane. C. Cholesterol. D. 
Cycloartenol. E. Lanosterol. F. Ergosterol. 
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17. In animals, the main sterol is cholesterol (Figure 1.1 C). It is amphipathic with a 
polar head group (the hydroxyl group at C-3) and a nonpolar hydrocarbon body (the 
steroid nucleus and the hydrocarbon side chain at C-17). The whole length of this 
molecule is equivalent to a 16-carbon fatty acid in its extended form. The detailed 
properties of cholesterol will be discussed in the next section. 
In plants and fungi, all sterols are called phytosterols. The first phytosterol was 
isolated by Hesse (1878) from Phytostigma venenosum. So far, more than 200 kinds 
of phytosterols have been identified. All of them are derived in plant from 
cycloartenol (Figure 1.1 D) and in fungi from lanosterol (Figure 1.1 E). In yeast and 
ergot, the main sterol is ergosterol (Figure 1.1 F). 
 
1.1.2 The Features and Functions of Cholesterol 
Free cholesterol is an essential component of various organelle membranes. In the 
plasma membrane, the cholesterol concentration reaches as much as 20–25% of total 
lipids (Dietschy and Turley, 2004). However, there is no cholesterol in microbes. Due 
to its distinctive property, it was evolved as one of the constituents of biological 
membranes after long-term selection.  
Although as mentioned above, cholesterol is amphipathic, unlike phospholipids, 
the hydrophobic nature of cholesterol is so strong that it is impossible to form a sheet 
structure on its own, unless it is inserted among phospholipids. The hydroxyl group of 
cholesterol forms a hydrogen bond with a phospholipid carbonyl oxygen atom while 
the bulky steroid moiety and the flexible hydrocarbon tail are directed to the 
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hydrophobic inner portion of the membrane. In this way, at the outer surface of lipid 
bilayer leaflets, cholesterol limits the random movement of the polar heads of the 
phospholipids. Meanwhile, cholesterol also reduces the interaction of the fatty acyl 
chains, and thus inhibits transition to the crystalline state. It causes the inner regions 
of lipid bilayer to become slightly more fluid. A membrane with a high concentration 
of cholesterol has a fluidity that is intermediate between the liquid crystal and gel 
states. 
The contrary properties of cholesterol endow mammalian membrane with more 
complex properties than prokaryotic membrane. At physiological temperature, as a 
rigid and waxy molecule, cholesterol helps to condense the phospholipids bilayer and 
thus provides stability to a membrane (ability to resist breakdown, strength, chemical 
attack and temperature) and reduces permeability (its ability to allow other chemicals 
and proteins to move in and out of the membrane). Therefore, membranes with high 
ratios of cholesterol to other lipids, such as the myelin membranes of sheath in the 
central nervous system, have high stability and comparatively low permeability to 
chemicals, nutrients and proteins. As such, the primary function of cholesterol in 
membranes appears to be a protective barrier. 
Besides maintenance of membrane fluidity and permeability, cholesterol is also 
required for lateral domain or lipid rafts formation and for regulation of integral 
membrane protein function, and also for transcriptional regulation (Bagnat, 2000; 
Pike, 2003; Simons and Ikonen, 1997; Simons and Toomre, 2000; Meer, 2002). Lipid 
rafts are often rich in cholesterol and sphingolipids. Attributing to the lack of double 
                                                                                   - 24 - 
bonds in sphingolipid hydrocarbon chains, the affinity between cholesterol and 
sphingolipids is very high. The close packing of cholesterol and sphingolipids in 
membrane bilayers helps to stabilize the complex supramolecular structures that are 
formed among lipids, receptors, adaptor proteins and the cytoskeleton at the cell 
surface (Bloom et al., 1991; Mouritsen and Jorgensen, 1994). Recent studies (Scheel 
et al., 1999) indicated that the function of some membrane associated transporters and 
signaling proteins are cholesterol dependent.  
In addition to cholesterol being an important component of membranes, it is also 
the precursor for vitamin D, bile acids and steroid hormones in animals, including 
glucocorticoids, mineralocorticoids and sex hormones (progesterone, estrogen and 
testosterone). As compared to other signal molecules, steroid hormones are highly 
hydrophobic and can pass through membranes easily. After crossing the plasma 
membrane (PM), steroid hormones interact with intracellular receptors, forming 
complexes which regulate the transcription of specific genes (Lodish et al., 1999). 
These derivatives of cholesterol play key roles in multiple physiological processes. 
For example, glucocorticoids (such as cortisol) primarily control the metabolism of 
carbohydrates. Mineralocorticoids (such as aldosterone) regulate the concentrations of 
electrolytes in the blood. Steroid hormones affect sexual development, sexual 
behavior, and a variety of other reproductive and nonreproductive functions. Vitamin 
D directly influences bone health. At the same time, bile acid facilitates the absorption 
of dietary fat. These cholesterol derivatives interact with different other biomolecules 
which confer remarkable properties to living organisms. 
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 1.1.3 Biosynthesis of Cholesterol 
De novo cholesterol biosynthesis from acetyl-CoA is the main source in most cells 
(Spady and Dietschy, 1983). Most of the cholesterol in animals is synthesized in the 
liver. With the participation of nearly 30 enzymes, the 27-carbon cholesterol is 
synthesized from a two-carbon substrate, acetate (Bloch, 1991), which is activated by 
coenzyme A to form acetyl-CoA. The process (Figure 1.2) includes 5 major stages: 1. 
acetyl-CoAs are converted to 3-hydroxy- 3-methylglutaryl- CoA (HMG-CoA); 2. 
HMG-CoA is converted to mevalonate; 3. mevalonate is converted to the active 
isoprene unit, isopentenyl pyrophosphate (IPP), with the concomitant loss of CO2; 4. 
six 5-carbon isoprene units are condensed into a 30 carbon linear squalene molecule; 
5. squalene is cyclisated and further processed to cholesterol.  
Among the thirty enzymes, HMG-CoA reductase (HMGR), which reduces 
HMG-CoA to form mevalonate, is the rate limiting enzyme of cholesterol 
biosynthesis. A 15-carbon intermediate, farnesyl pyrophosphate, during the fourth 
stage, is the committed step for polyisoprene biosynthesis (Beytia and Porter, 1976; 
Cough and Hemming, 1970). In addition to cholesterol biosynthesis, this compound 
also contributes to two other pathways for the synthesis of ubiquinone and dolichol.  
 
1.1.4 Cholesterol Metabolism 
The biosynthesis of cholesterol is a highly complicated and energy-expensive 
process. Thus, cholesterol of a cell, either generated by endogenous synthesis or 
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Figure 1.2 Biosynthesis of cholesterol. Biosynthesis of cholesterol include 5 major steps. 
1. Acetyl-CoAs are converted to HMG-CoA; 2. HMG-CoA is converted to mevalonate by 
HMG-CoA reductase; 3. Mevalonate is converted to the active isoprene units, isopentenyl 
pyrophosphate (IPP); 4. Six 5-carbon isoprene units are condensed into a 30 carbon linear 
squalene molecule; 5. Squalene is cyclisated and further processed to cholesterol (Bloch, 
1965). 
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obtained through internalization, is seldomly degraded. Usually, cholesterol in a cell 
has five fates: serving as membrane component, being oxidized into oxysterol, 
converted into steroid hormones or vitamins, excreted in the form of bile acid, or 
stored as cholesteryl ester. 
Cholesteryl ester is formed in the liver, catalyzed by acyl-CoA: cholesterol acyl 
transferase (ACAT). A fatty acid chain from coenzyme A is transferred to the hydroxyl 
group of cholesterol. Cholesteryl esters are transported under facility of lipoprotein 
particles to other tissues, or are stored in the liver.  
 
1.2 Intracellular Cholesterol Homeostasis 
1.2.1 Introduction to Cholesterol Homeostasis 
Cholesterol homeostasis is a very broad concept that covers every aspect of 
cholesterol in the biological system, including its amount, ratio to other membrane 
lipids, distribution, localization, and dynamic turnover.  
As a critical component of mammalian cell membranes, a precursor for many 
steroid hormones that play essential roles in different stages of life and also as a 
precursor of bile acid and vitamin D, the cholesterol level is always kept constant due 
to tight, delicate and multiple regulations that result from not only intracellular 
communication but also interactions between cells, tissues, and even organs.  
Considerable evidence shows that in the whole animal, from mouse to cat, from 
tiger to human beings, the average concentration of cholesterol is at about 2.2 mg/g 
fresh tissue (Dietschy and Wilson, 1968). In the steady state, the concentration of 
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cholesterol in cell membranes is maintained constant at a level that can be used as a 
marker to identify each particular tissue (Dietschy and Turley, 2004). The highest 
concentration of cholesterol is found in the brain, at 15-20 mg/g in many species and 
these cholesterol molecules are mainly unesterified form, whereas most of the sterols 
in adrenal gland and other endocrine organs are stored as esters. However, the average 
concentration of free cholesterol in cell membranes of these endocrine tissues is only 
2-4 mg/g, as compared to 4-5 mg/g in the lung and kidney and 1.4 mg/g in the striated 
muscle of carcass. In the latter tissues, cholesterol is mainly localized in the plasma 
membrane in an unesterified form (Nervi and Dietschy, 1975). Actually, the level of 
cholesteryl esters increases with the intake of exogenous dietary cholesterol and this 
increase occurs only in the liver and, to a much lesser extent, in the intestine (Nervi 
and Dietschy, 1975; Andersen et al., 1982). 
Similar to its distribution in different organs, the concentration of cholesterol 
varies in diverse organelles while remaining constant at its specific place. PM 
contains the highest concentration of cholesterol (Warnock et al., 1993). It has been 
estimated that approximately 65–80% of the free cholesterol in cells is in the PM. In 
contrast, the cholesterol in the ER probably accounts for just 0.1–2% of the free 
cholesterol in fibroblasts. Interestingly, it has been found that a cholesterol gradient 
occurs in the secretory pathway, with the lowest concentrations in the ER and the cis 
side of the Golgi apparatus and higher concentrations in the trans Golgi, trans-Golgi 
network (TGN) (Orci et al., 1981; Coxey et al., 1993; Bretscher and Munro, 1993), 
endosomes and the endosome-recycling compartment (Evans and Hardison, 1985; 
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Hornick et al., 1997; Hao et al., 2001). To maintain such a heterogeneous distribution 
of cholesterol (and other lipids) along the secretory and endocytic pathways despite of 
a continuous flow of transport vesicles should be pivotal for the functions of cells. 
Although the levels of cholesterol in both the membranes and the whole animal 
essentially remain constant, there is a continuous flow of cholesterol from the ER to 
the PM, and from PM to the intracellular organelles in all tissues. Therefore, it is a 
dynamic balance. The amount of cholesterol transported from all peripheral organs to 
the liver in human is only 10 mg/day/kg, as compared to greater than 100 mg/day/kg 
in mouse (Dietschy and Turley, 2002; Kleiber, 1961). Similar comparisons indicate  
only 0.7% replacement of cholesterol each day in the human plasma membranes in 
contrast to 8% of the mouse plasma membranes (Dietschy and Turley, 2002; Xie et al., 
2003). This relationship has also been observed in organs from other species (Spady 
and Dietschy, 1983; Aiello and Wheeler, 1995; Dietschy and Turley, 2001).  
As discussed above, cholesterol homeostasis means a subtle and dynamic balance 
of cholesterol. Interestingly, with respect to both sides of cholesterol homeostasis, in 
most organisms, the main challenge for a cell is not the lack of cholesterol, but excess 
of cholesterol (Small, 1988; Warner et al. 1995). Too high concentration of free 
cholesterol is toxic to cells. Thus, in most cases, the struggle of the organisms to 
maintain cholesterol homeostasis is more or less the action against free cholesterol 
accumulation. A safe and energy-conserving way to solve the problem is converting 
the cholesterol to a more hydrophobic and thus inert form as cholesteryl ester. Another 
important protective mechanism is the cellular efflux of cholesterol and conversion to 
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certain cholesterol-derived oxysterols. In addition, some of the physiological 
pathways, such as steroid and bile acid biosynthesis, may help limit the accumulation 
of intracellular free cholesterol in steroidogenic cells and hepatocytes, respectively. 
Another very important strategy is to control cholesterol synthesis. 
In the next section, we will discuss the multiple mechanisms for a cell to maintain 
cholesterol homeostasis. Our discussion will focus on two parts: regulation of 
cholesterol metabolism and cholesterol transport. 
 
1.2.2 A Key Domain and Protein Involved in Intracellular Cholesterol 
Homeostasis 
In the process for maintaining cholesterol homeostasis, the key event is to “sense” 
the fluctuations in cholesterol levels so that the cells can respond effectively, correctly 
and immediately. The central question is how a cell senses the signal of cholesterol 
levels, its distribution and localization. Such cholesterol-initiated or dependent 
mechanisms are yet to be understood.  
As mentioned before, due to its highly hydrophobic nature, free cholesterol 
resides in membranes. Thus, the “cholesterol-sensing” mechanism requires to 
consider this special property of cholesterol. So far, two smart strategies have been 
discovered which may provide clues for such a mechanism. One is the occurrence of 
hydrophobic membrane domain, i.e. “sterol sensing domain” (SSD)in some proteins, 
which may render the ability to detect the fluctuation of cholesterol levels in the 
membrane. The other is to transfer cholesterol into a more hydrophilic form, i.e. the 
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oxysterols, so that relative to cholesterol, the signal can be more readily transducted in 
an intracellular aqueous environment. 
 
1.2.2.1. Sterol-sensing Domain (SSD) Proteins 
SSD is a phylogenetically conserved domain, which consists of approximately 
180 amino acid residues organized into a cluster of five consecutive 
membrane-spanning domains. So far, several classes of proteins, which are involved 
in metabolism, transport and distribution of cholesterol and the embryonic 
development, have been identified to share SSD (Kuwabara and Labouesse, 2002).  
The first identified SSD-containing protein was HMGR. Although the 
SSD-carrying region of HMGR is not required for its enzymatic activity, it is 
suggested that this domain accelerates the degradation of HMGR in response to high 
levels of cholesterol. 
NPC1 is another protein containing SSD. Clinical studies show that SSD is 
necessary to maintain activity of NPC1. It has been found that missense mutations in 
the SSD region are associated with loss of function of the NPC1 protein, which cause 
cholesterol accumulation in the endosome/lysosome system (Millat et al., 2001).  
The role of SSD in SCAP is relatively clear. When the intracellular cholesterol 
level is low, this domain directly interacts with ER-retention proteins, Insig1 or Insig2, 
and blocks the incorporation of the SCAP-SREBP complex into budding vesicles 
destined for the Golgi (Yang et al., 2000; Nohturfft et al., 2000). The detailed 
regulatory mechanism will be discussed later. 
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Other protein containing SSD include 7-dehydrocholesterol reductase (7DHCR), 
an enzyme involved in cholesterol biosynthesis (Witsch-Baumgartner et al., 2001), 
Patched (Ptc), a receptor binding to the cholesterol-modified morphogen Hedgehog 
(Hh) as a tumour suppressor, Dispatched (Disp), a membrane protein that facilitates 
the release of Hh from Hh-producing cells, PTR (Ptc-related), a membrane protein of 
function unknown highly homologous to Ptc (Ingham and McMahon, 2001; Burke et 
al., 1999; Kuwabara et al., 2000), and NPC1L1, a transport protein that facilitates diet 
cholesterol absorption in the intestine (Altmann et al., 2004).  
In this group of proteins, the SSD may act as a regulatory domain. Evidence from 
studies on HMG-CoA reductase and SCAP indicates that SSD may sense the 
cholesterol concentration in the ER membrane and transduces this signal to regulate 
cholesterol biosynthesis. However, the available biochemical information is 
insufficient to determine whether SSD in all proteins shares a common underlying 
function. Although the general function of SSD is yet to be clarified, it implicates that 
SSD may have a key role in different aspects of cholesterol homeostasis or 
cholesterol-linked signaling (Kuwabara and Labouesse, 2002) 
 
1.2.2.2 Oxysterol and OSBP 
Oxysterols are a group of oxygenated chemicals derived from sterols by 
enzymatic or nonenzymatic oxidative processes mainly occurring in the mitochondria, 
the ER and peroxisomes (Lund et al. 1998; Russell 2000). They are intermediates in 
bile acid and steroid hormone synthetic pathways from cholesterol (Smith, 1996; 
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Russell, 2000; Björkhem et al., 2002). As compared to cholesterol, the physiological 
concentration of all oxysterols, even the most abundant 27-hydroxycholesterol 
(27HC), 24(S)-HC and 7α-HC, is very low. It is at least 10,000-fold less than the 
concentration of cholesterol (Brown and Jessup 1999). By far the clearest role for this 
diverse group of compounds is as a signal of excessive cholesterol in the regulation of 
cholesterol homeostasis. Certain oxysterols, such as 27HC in peripheral tissues and 
24(S)-HC in the central nervous system, are suggested to act as an alternative form of 
sterol efflux from peripheral cells because of their better solubility than cholesterol 
(Babiker et al., 1997; Lütjohann et al., 1996).  
24(S), 25-epoxycholesterol [24(S),25-epoxy], 24(S)-HC and 22(R)-HC is the 
native ligand of liver X receptors (LXRα and LXRβ) (Janowski et al. 1996; Lehmann 
et al., 1997). LXR forms a heterodimer nuclear hormone receptor with retinoid X 
receptors (RXR). This heterodimer molecule functions as transcription factor, which 
activates expression of the genes which control cholesterol adsorption in the intestine 
and are involved in the secretion of cholesterol and bile acid. Oxysterols thus 
represent a signal of excessive cholesterol and activate its removal.  
Another protein which binds oxysterols is OSBP. 25HC and several other 
oxysterols are the native ligands in cells. Overexpression of OSBP causes 80% 
increase of cholesterol biosynthesis and 50% decrease of cholesteryl ester, whereas 
the effect of 25 HC is just opposite to the effect of OSBP overepression (Lagace et al., 
1997). A high 25HC level in cells causes translocation of OSBP from the cytosol or 
cytoplasmic vesicles to the Golgi apparatus (Ridgway et al., 1992). In addition, OSBP 
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associates with ER membranes by interacting with VAMP associated protein (VAP, 
VAP-A and VAP-B) (Wyles et al., 2002). Both VAP-A and VAP-B (INSIG1 and 2) 
associate with SCAP, which interacts with SREBP on the ER and Golgi membranes 
(Yang et al. 2002). Although these evidences showed that OSBP may control 
cholesterol biosynthesis or transport, the molecular mechanism still remains to be 
elucidated. 
Seven OSBP-related proteins (ORP) in Saccharomyces cerevisiae (Beh et al., 
2001) and twelve in both humans (Lehto et al., 2001; Jaworski et al., 2001) and mice 
(Anniss et al., 2002) have been identified. All of them comprise a domain with 400 
amino acid residues homologous to the C-terminus of OSBP. Some of them include a 
pleckstrin homology (PH) domain, a membrane targeting domain (Ridgway et al., 
1992; Lagace et al., 1997; Levine and Munro, 1998, 2002; Johansson et al., 2003). 
Osh1p in S. cerevisiae is associated with nucleus-vacuole junction (NVJ), the only 
known membrane contact site (Levine and Munro 2001). The homologs of Osh1p, 
Osh2p and Osh3p can be recruited to membrane contact site between ER and PM by 
Scs2p, which is a VAP homolog in yeast (Loewen et al., 2003). The localization 
results infer the possible function of ORP in lipid trafficking between membranes. So 
far no data are available about the nature of lipid ligands of the ORPs. 
 
1.2.3 The Role of Cholesterol Metabolism, Esterification and Cholesterol 
Transport in Cholesterol Homeostasis 
As mentioned above, excessive cholesterol is toxic to cells (Small, 1988; Warner 
                                                                                   - 36 - 
et al., 1995), hence cellular cholesterol levels are tightly controlled by a diverse set of 
homeostatic activities. Physiologically, it appears that the level of ER cholesterol 
plays a critical regulatory role in cholesterol homeostasis. Due to the low 
concentration of cholesterol in the ER, even slight changes in the total cholesterol 
pool can significantly change the cholesterol concentration in the ER and thus cause 
response of factors in the ER (Lange and Steck, 1997). Therefore, the ER appears to 
be a sensor of cholesterol (Lange, 1994; Lange and Steck, 1996).  
In the next several sections, cholesterol homeostasis will be discussed around the 
central part of cholesterol pool, the ER. 
 
1.2.3.1 Regulation of HMG-CoA Reductase 
As mentioned above, HMGR is the rate-limiting enzyme in cholesterol 
biosynthesis which catalyzes the synthesis of mevalonic acid, using HMG-CoA as 
substrate. It is the initial and important control point not only in the pathway of sterol 
biosynthesis, but also in all isoprenoid biosynthetic pathways because its downstream 
product, farnesyl pyrophosphate, is the branch point of these biochemical pathways. 
Hence the regulation of HMGR is important. 
HMGR is an ER membrane protein. In CHO cell it comprises of a N-terminal 
domain with 339 amino acid residues and a C-terminal domain with 548 amino acid 
residues. The catalytic activity of this enzyme is attributed to the C-terminal domain 
(Liscum et al., 1985). The amino-terminus is a membrane anchor domain, which 
includes 8 membrane-spanning regions, that also contain a conserved sterol-sensing 
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domain (SSD) (Roitelman et al., 1992). This domain is necessary and sufficient to 
mediate degradation of HMGR (Gil et al., 1985; Chun et al., 1990). 
The regulation of HMGR is coordinated mainly by four distinct mechanisms: 
control of gene expression, phosphorylation of the enzyme, feedback inhibition and 
rate of enzyme degradation (Hampton et al., 1996). Cholesterol plays an key role in 
the regulation of HMGR. 
First, the activity of HMGR is inhibited by the intermediate, mevalonate, and by 
the end product, cholesterol. In cultured cells in the presence of saturated LDL, the 
enzyme retains only 2% of activity. It cannot be completely inhibited because the 
remaining activity is required for the synthesis of other important isoprenoid 
compounds (Brown and Goldstein, 1980).  
Second, the degradation of HMGR is accelerated when cells are cultured with 
cholesterol- or mevalonate-rich media (Faust et al., 1982; Edward et al., 1983). An 
increase in the cellular cholesterol level also accelerates the degradation of HMGR by 
a proteasome-mediated process (Hampton, 2002). This suggests that cholesterol is the 
primary compound to regulate the degradation of HMGR.  
The regulatory process of HMG-R is mediated by its SSD motif (Sever et al., 
2002). Binding between the SSD of HMGR and Insigs is required to accelerate 
degradation of HMGR. An ubiquitin ligase E3, Gp78, which binds to Insig1, is 
required for ubiquitination of HMGR (Song et al., 2005). At the same time, Gp78 also 
binds to an ATPase, VCP, which was previously shown to be involved in recognition 
and degradation of ER-associated degradation proteins.  
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All these results implicate an SSD-mediated regulation of HMGR by cholesterol. 
However, the detailed mechanism how Insigs and cholesterol levels regulate the 
stability of HMG-R remains to be elucidated. In addition to cholesterol, the enzyme 
degradation is also mediated by nonsterol products. The mechanism is under study in 
yeast and cultured animal cells (Gil et al., 1985; Roitelman et al., 1992; McGee et al., 
1996; Hampton, 1998; Ravid et al., 2000). 
Third, cholesterol and isoprenoids not only control feedback regulation on HMG- 
CoA reductase directly and accelerate the degradation of this enzyme, but also 
regulate transcription and block translation of the HMGR mRNA (Goldstein and 
Brown, 1990). The translational effects are evoked by nonsterol mevalonate-derived 
products, but the mechanism is entirely unknown (Nakanishi et al.., 1988). The 
transcriptional factors binding to the promoter of HMGR are sterol regulatory element 
binding proteins (SREBPs). These proteins will be discussed in the following section. 
Fourth, Feingold et al. (1993) and Hardardottir et al. (1994) showed that treatment 
with lipopolysaccharide (LPS) or certain cytokines, such as TNF, IL-1, specifically 
increase HMGR mRNA levels, while other related mRNA, e.g. LDL-receptor mRNA, 
remain unchanged.  
In addition, according to Sato et al (1993), the phosphorylation of HMGR by 
AMP-activated protein kinase, AMPK, leads to inhibition of HMGR activity when 
ATP is depleted. 
 
1.2.3.2 The Activation of SREBPs 
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SREBPs are a family of membrane-bound transcription factors, which are 
negatively regulated by cholesterol and oxysterols (Brown and Goldstein, 1997). 
SREBPs include three isoforms, SREBP1a, SREBP1c and SREBP2. Among them, 
SREBP1a and SREBP1c are splice variants from the same gene. SREBPs are 
three-domain membrane proteins (Brown and Goldstein, 1997), located on the ER 
membrane and nuclear envelop in a hairpin orientation. The N-terminus was a 
basic-helix-loop-helix-leucine zipper (bHLH) containing transcription factor motif. 
The C-terminus is a regulatory domain to interact with the SSD of SCAP (Sakai et al., 
1996). Both N-terminus and C-terminus of the protein are exposed to cytoplasm. The 
central part is a 2-transmembrane spanning domain.  
The maturation of SREBP is under the control of SREBP cleavage-activating 
protein (SCAP), a central regulator of cholesterol metabolism (McGee el al., 1996; 
Sakai et al., 1996). SCAP is a large ER membrane protein, which contains at least 8 
transmembrane domains. The C-terminal part of SCAP contains 4 motifs called 
WD40 repeats (DeBose-Boyd et al., 1999; Nohturfft et al., 1999). The WD40 repeats 
directly interact with the C-terminal regulatory region of SREBP and mediate the 
sterol-regulated transport of SREBP from the ER to Golgi (Hua et al., 1996).  
When the cholesterol level is low, SCAP can escort SREBP2 to the Golgi 
complex (Sakai et al., 1997, 1998). This process is essential for S1P-mediated 
cleavage of SREBP. However, high cholesterol levels can inhibit the movement. 
The transmembrane spans 2-6 of SCAP form a SSD. Therefore, SCAP functions 
as a cholesterol sensor (Brown and Goldstein, 1999; Goldstein et al., 2002). 
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Cholesterol can bind to the transmembrane region of SCAP, but there is no evidence 
to prove that oxysterol, such as 19-, 25-, and 27-hydroxycholesterol, have such effect 
(Radhakrishnan et al., 2004). At high cellular cholesterol levels, the SSD of SCAP 
interacts with Insig1 and Insig2, two ER proteins, which serve as anchors on the ER 
(Yang et al., 2002; Yabe et al., 2002). It was suggested that increased cholesterol 
levels in the ER membrane trigger a conformational change of SCAP and stimulate its 
binding to Insigs (Brown et al., 2002; Adams et al., 2003). Insigs stabilize 
conformational change of SCAP induced by cholesterol. Binding with Insig1 and 
Insig2 leads the SCAP-SREBP complex to be retained on the ER membrane and 
prevents the proteolytic activation of SREBP in the Golgi complex. The detailed 
mechanism on how cholesterol leads to the conformational change of SCAP is still 
unknown. 
When SREBPs translocate to the Golgi, they are cleaved at their lumenal loop by 
a protease located in the Golgi membrane, site-1 protease (S1P) (Duncan et al., 1997). 
The two parts of SREBPs are still embedded in the Golgi membrane (Sakai et al., 
1996). A second Golgi membrane-localized protease, site-2 protease (S2P), cleaves at 
a site of the N-terminal intermediate fragment (Duncan et al., 1998). This site is just 
within the transmembrane span and locates at the boundary of hydrophobic and 
hydrophilic amino acids. Cholesterol selectively inhibits the activity of S1P, but does 
not affect S2P (Sakai et al., 1996). The two-enzyme process generates a soluble 
activated bHLH transcription factor. This transcription factor translocates into the 
nucleus and activates the expression of genes by binding to the sterol regulatory 
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element 1 (SRE-1), an octamer regulatory sequence. The activated bHLH in the 
nucleus is rapidly degraded when cholesterol levels are high (Wang et al., 1994). 
Activated SREBPs control the expression of genes for the low-density lipoprotein 
receptor, HMG-CoA reductase and more than 30 other genes involved in the 
biosynthesis of cholesterol, triacylglycerols, phospholipids and fatty acids (Goldstein 
and Brown, 1990; Brown and Goldstein, 1997). In addition, SREBPs also negatively 
control the expression of the caveolin gene (Bist et al., 1997), perhaps because 
caveolae mediates cholesterol export (Babitt et al., 1997; Fielding CJ and Fielding PE, 
1997). 
 
1.2.3.3 The Cholesterol Esterification Enzyme: ACAT 
Excessive cholesterol is converted to the non-toxic metabolite, cholesteryl ester, 
by acyl-CoA: cholesterol acyltransferase (ACAT) (Goodman et al., 1964). ACAT is 
an integral membrane protein (Doolittle and Chang, 1982) residing in the rough ER 
membrane (Hashimoto and Fogelman, 1980; Reinhart et al., 1987). The 4kb human 
ACAT1 gene was first identified by Chang et al (1993). The ACAT1 cDNA contains 
an open reading frame (ORF) of 1650bps, encoding a protein of 550 amino acids 
(Chang et al 1994). Northern blot analysis revealed that there are four transcripts of 
the human ACAT gene. They are 7kb, 4.8kb, 4.0kb and 3.1kb in length, respectively, 
and have the same coding sequence. The proximal promoter initiates the production 
of the two small transcripts and the distal promoter is responsible for the 4.8kb 
transcript; so far, the promoter of the 7kb transcript is still unknown. 
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ACAT has maximum activity at pH6.6-7.1 (Goodman et al., 1964). The order of 
the fatty acyl-CoA preference of ACAT is oleate > palmitate > stearate > linoleate. 
Some long chain fatty acids, such as oleate (18:1), arachidonate (20:4) and 
eicosapentaenoate (20:5) stimulate ACAT activity in cultured cells (Rumsey et al., 
1995). In addition, the different side chains of phospholipids can induce different 
ACAT activity (Mathur et al., 1983). 
ACAT activity increase after LDL feeding (Hashimoto and Dayton, 1977). 
Interestingly, under this condition, the activity of ACAT is insensitive to protein 
synthesis inhibitors. It implicates that ACAT may not be transcriptionally activated by 
cholesterol (Goldstein and Brown, 1977). Further investigation (Doolittle and Chang, 
1982) confirmed that this activity increase is attributed to the availability of the 
substrate of cholesterol, instead of the amount of the enzyme protein (Chang et al., 
1995; Matsuda et al., 1996).  
The activity curve of ACAT is sigmoidal (Doolittle and Chang, 1982; Cadigan 
and Chang, 1988). It supports that ACAT is an allosteric enzyme and the binding of 
cholesterol to ACAT leads to conformational changes that activate the enzyme. The 
sigmoidal activity curve of the allosteric enzyme indicates that the enzyme can be 
activated only when the cholesterol level exceeds a certain critical threshold. 
In addition, ACAT gene expression is also regulated. Two of the four ACAT 
mRNAs are increased significantly during monocyte-macrophage differentiation 
(Wang et al., 1996). The increase in ACAT mRNA leads to a 14-fold increase in the 
Vmax of the enzyme. According to the results of Pape et al. (1995) and Uelmen et al. 
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(1995), a high fat, high cholesterol diet increases ACAT1 mRNA level about 2-3 fold 
in mouse or rabbit liver.  
Not only cholesterol but also oxysterols stimulate ACAT activity (Brown and 
Goldstein, 1975, 1983). Certain oxygenated sterols can activate ACAT activity and 
ACAT can use 25-hydroxycholesterol as an alternative substrate (Cheng et al., 1995). 
Other agents regulating ACAT activity are fatty acids and phospholipids, however, 
the detailed mechanisms remain to be elucidated. 
 
1.2.3.4 Cholesterol Transport through the PM 
Cholesterol supply for cell comes from, internal and external sources. Internal 
cholesterol comes from de novo synthesis and release from cholesteryl esters in lipid 
droplets by neutral cholesteryl ester hydrolase (nCEH). The external cholesterol 
comes from cholesterol that is excreted from other cells, and intake of dietary 
cholesterol. 
In order to maintain the dynamic balance and to facilitate the proper distribution 
of cholesterol in the body and in cells, nature has evolved a set of quite sophisticated 
mechanism to transport cholesterol to its destinations. 
Because of the highly hydrophobic nature of cholesterol, a carrier is required to 
transport it in the aqueous environment, such as blood plasma or the intracellular 
matrix. Another strategy is to esterify cholesterol by long chain fatty acids. Both free 
cholesterol and cholesteryl ester are assembled into a particle by interaction with 
carrier lipoproteins. There are four kinds of lipoproteins: low density lipoprotein 
                                                                                   - 44 - 
(LDL), very low-density lipoprotein (VLDL), intermediate density lipoprotein (IDL) 
and high-density lipoprotein (HDL). In addition, between organelles in a cell, both the 
modulation of the cholesterol content of transport vesicles and non-vesicular transport 
of cholesterol are likely to contribute to its intracellular distribution. 
In this and next sections, cholesterol transport in the whole organism will be 
reviewed. 
On one hand, cholesterol in the outer leaflet of PM continuously leaks into the 
surrounding lymph (Yokoyama, 2000; Fielding and Fielding, 2001). In order to 
maintain the concentration of cholesterol in PM, cells need to compensate this loss. 
On the other hand, the plasma membrane is a hydrophobic interface with aqueous 
phases present on both sides of the PM. Therefore, carrier proteins are often required 
to transport cholesterol into cells or to mediate efflux into the extracellular matrix. 
Once the cholesterol and cholesteryl ester assemble into lipoproteins, the whole 
complex is hydrophilic. Various mechanisms have been developed to facilitate 
cholesterol transport across the PM.  
In human plasma, LDL is the main cholesterol-carrying lipoprotein (Gofman et al., 
1954). The study about LDL transport across the PM was initiated from investigations 
on a natal disease, Familial Hypercholesterolaemia (FH) (Goldstein and Brown, 1973). 
Patients of this disease show a high blood-cholesterol level even at young age. 
Frequently, they develop into myocardial infarction. 
Early studies show that the disease may be caused by mutations of the LDL 
receptor, which binds chylomicrons as well as LDL (Brown et al., 1974; Anderson et 
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al., 1976 and Brown et al. 1976). The molecular weight of mature LDL receptor is 
about 160kDa (Tolleshaug et al., 1982). Schneider et al. (1982) purified and partially 
sequenced this protein. Using this sequence, the full-length human LDL receptor 
complementary DNA (cDNA) was isolated (Russell et al., 1983; Yamamoto, 1984). 
After LDLs binding to receptors, the complexes are aggregated in the 
clathrin-coated pits and internalized to form early endosomes (Sparks, 1983). This 
receptor disassociates from LDL with the decrease in pH (Maxfield and Helenius, 
1983) and is recycled (Goldstein et al., 1979). The cholesteryl ester in LDL is 
transported to lysosomes, and then hydrolyzed into free cholesterol and fatty acids 
(Duve, 1983). Finally, a pathway involving NPC1 and NPC2 distributes cholesterol to 
their destinations where they serve as structural component, metabolic substrate or 
regulatory molecule (Loftus et al., 1997; Xie et al., 1999).  
In mammalian cells, endocytosis is the main pathway to transport cholesterol 
across the PM (Jacobs et al., 1997). Cholesterol transport is defective in endocytotic 
mutant CHO cells. Progesterone and hydrophobic amines can inhibit cholesterol 
export from endosomes (Lange, 1994; Harmala et al., 1993; 1994) and then inhibit 
cholesterol transport from the PM to the ER. Drugs, which can disassemble 
microtubules, have the same effect.  
In most species, most of LDL (80%) generated by liver is absorbed back by 
hepatocytes. Less than 20% of the LDL is taken up by cells of the peripheral organs, 
where de novo synthesis is the major source of cholesterol (Dietschy and Turley, 
2002). 
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Besides LDL receptor mediated endocytosis, evidence shows that there are other 
mechanisms of cholesterol transport from the PM to the ER. Using S. cerevisiae as a 
model, Prinz (2002) showed that mutations in genes coding for endocytotic 
components did not affect the rate of sterol transportation. Some unpublished results 
of his group also indicate that at the close contact between PM and ER membrane, an 
ATP dependent pathway may be the main mechanism in yeast which bypasses 
endocytosis.  
Another cholesterol carrier is HDL, which contains cholesterol, cholesteryl ester 
and the main lipoprotein ApoA-I. It is often produced in peripheral organs and central 
nervous system, from where it is transported to steroidogenic cells for steroid 
hormones, or to the liver for further metabolism, including synthesis of bile acids and 
excretion. It seems that this lipoprotein reduces cholesterol accumulation in peripheral 
organs. Therefore, some scientists call it “good” cholesterol. 
The specific HDL receptor is palmitoylated SR-BI (Acton et al., 1996; Landschulz 
et al., 1996). SR-BI is highly expressed in cells of liver, endocrine, ovary, testes, and 
adrenal gland, which are dependent on HDL cholesterol for bile acid or hormone 
synthesis. Therefore, this receptor mediates a major delivery route of cholesterol 
which is used in steroidogenic cells and their steroidogenic pathways (Azhar et al., 
1998; Briand et al., 2003).  
SR-BI delivers HDL cholesteryl ester to liver and steroidogenic tissues by a 
two-step process different from LDL receptor-mediated endocytosis. A mutation in 
NPC1 can block cholesterol transport from LDL in lysosomes, but does not affect 
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uptake and processing of cholesteryl ester from HDL (Xie et al., 2000). This two-step 
process is named selective uptake (Acton et al., 1996). In the first step, the lipoprotein 
in HDL particles, ApoA-I binds to the extracellular domain of SR-BI. In the second 
step, cholesteryl ester in the core is selectively transferred to the PM (Rinninger and 
Pittman, 1987).  
SR-BI colocalizes with caveolin-1 and cholesteryl ester in HDL is translocated 
into caveolae (Babitt et al., 1997; Malerod et al. 2002). A neutral hydrolase is 
responsible for hydrolysis of HDL cholesteryl ester (Connelly et al., 2003; Kraemer et 
al., 2002). 
An alternative mRNA splicing variant, SR-BII, whose cytoplasmic C terminus is 
different from that of SR-BI, can effectively internalize HDL (Eckhardt et al., 2004).  
Recently, Davies et al. (2000) and Altmann et al. (2004) reported that NPC1L1 
takes up free cholesterol into enterocytes from mixed micelles in the intestine. This 
gene shares 42% amino acid identity and 51% similarity to NPC1 (Davies et al., 
2000). Its mechanism remains to be further elucidated. 
There are several known mechanisms to control cholesterol efflux from the PM 
(Oram and Yokoyama, 1996; Mendez, 1997; Yokoyama, 1998). One of them is 
non-specific diffusion driven by a concentration gradient (Fielding and Fielding, 
2001). Three other possible mechanisms are by the transporters ABCA1, ABCG5/8 or 
an enzyme catalyzing cholesterol hydroxylation, respectively (Connor et al., 1969; 
Golomb et al., 2000; Virkkunen and Penttinen, 1984).  
According to Yokoyama (2000) and Liu et al. (2003), ABCA1 exports free 
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cholesterol from the plasma membrane of certain cells, such as macrophages. ABCA1 
mutations cause a defect in HDL formation (Orso et al., 2000; McNeish et al., 2000). 
However, the exact mechanism of this protein to facilitate assembly of HDL is still to 
be established. Mutations in the cytosolic domain that includes ATP-binding cassettes 
in ABCA1 result in a severe genetic disorder, Tangier disease (Brooks-Wilson et al., 
1999; Bodzioch et al., 1999; Rust et al., 1999). Further studies on this disease may 
lead to a better understanding of the relationship between HDL and coronary artery 
disease. 
ABCG5 and ABCG8 are ATP-binding cassette transporters. Lee et al. (2001) and 
Berge et al. (2000) first identified the ABCG5 gene. Later, Berge et al (2000) showed 
that ABCG8 is also located close to ABCG5 on the chromosome. The start codons of 
the two genes are arranged in a head to head direction. Berge et al. (2000) assumed 
that they share a common bidirectional promoter and regulatory elements. Both genes 
are expressed only in intestine and liver (Lee et al., 2001; Repa et al., 2002). 
ABCG5 and ABCG8 may form a functional heterodimer to remove free 
cholesterol from the PM or cytosol (Yu et al., 2002). Defect in either of the genes 
causes a genetic disease, sitosterolemia, also known as phytosterolemia or shellfish 
sterolemia (Berge et al., 2000). This disease is an autosomal recessive disorder which 
was first described by Bhattacharyya and Connor (1974). 
What is the physiological function of the ABCG5-ABCG8 dimer? Dietary sterols, 
including cholesterol and plant sterols, enter the intestinal epithelial cells by micellar 
transport. When they reach the lysosome via endocytosis, 99% of plant sterols, mainly 
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β-sitosterol, directly efflux back to the gut lumen by the facilitation of the 
ABCG5-ABCG8 heterodimer. 40-50% cholesterol may also efflux back so that this 
process can regulate total sterol absorption (Schmitz et al., 2001). Finally, the retained 
cholesterol is converted to cholesteryl ester by ACAT for storage or packaged into 
chylomicrons. In addition, ABCG5 and ABCG8 may also be involved in mediating 
cholesterol excretion into bile. 
Cholesterol is difficult to be metabolized in most types of cells. It can be 
converted into bile acid and steroid hormones in liver and steroidogenic cells, 
respectively. Although the pathways of bile acid synthesis remain to be clarified, it is 
clear that primary bile acid synthesis include four steps: 1. initiation by 
7α-hydroxylation of sterol, 2. further modification of sterol rings, 3. oxidation and 
shortening of the side chain, 4. conjugation with glycine or taurine. In step 1 and 3, 
the reactions produce intermediates, which are hydrolated in the 7α, 27, 25, and 24 
positions of cholesterol. The gradual hydroxylation increases the polarity and 
hydrophilicity of these molecules gradually. One fate of these compounds is to form 
bile acids. Bile acids synthesis is also involved in cholesterol homeostasis. Thus, it is 
also tightly regulated (Russell, 2003). 
In addition, cholesterol can be transferred between PM and HDL through the 
aqueous phase in plasma below the critical micellar concentration (Phillips et al., 
1987; Johnson et al., 1991; Ko et al., 1994). SR-BI may mediate the HDL cholesterol 
efflux (Llera-Moya et al., 1999). Esterification of free cholesterol in HDL by lecithin: 
cholesterol acyltransferase (LCAT) maintains the low cholesterol concentration on the 
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HDL surface. This low cholesterol concentration promotes more free cholesterol to 
flow into HDL mediated by SR-BI (Glomset, 1968).  
 
1.2.3.6 Intracellular Cholesterol Transport 
As mentioned above, cells maintain a cholesterol gradient across the secretory 
system, with the lowest concentrations in the ER and the cis side of the Golgi 
apparatus, higher concentrations in the trans-Golgi and trans-Golgi network (TGN) 
and highest concentration in the PM. Early endosomes and the endosome-recycling 
compartment are also rich in cholesterol (Orci et al., 1981; Coxey et al., 1993; 
Bretscher and Munro, 1993; Evans and Hardison, 1985; Hornick et al., 1997; Hao et 
al., 2001). Cholesterol recycles continuously between the ER and the PM (Lange et al., 
1993).  
Inside the cell, cholesterol transport occurs by a quite unclear and sophisticated 
mechanism. So far, we just know that at least four mechanisms may be involved in its 
transport (Prinz, 2002): 
First, cholesterol may be actively sorted before reaching its destination. 
Mukherjee et al. (1999, 2000) showed that various lipids are sorted in endocytic 
membranes. Furthermore, the ratio of cholesterol and sphingomyelin to phospholipids 
in COPI-coated vesicles are only 40-60% and 20-30% of that in their parents Golgi 
membrane, dependent on the source of Golgi membrane (Brugger et al., 2000). 
COPI-coated vesicles participate in retrograde transport from the Golgi network to the 
ER and intra-Golgi transport, including both anterograde and retrograde transport 
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within the Golgi complex (Orci et al., 1986; 1989; 1997; Ostermann et al., 1993; 
Volchuk et al., 2000). Although the mechanism of exclusion of cholesterol from 
COPI-coated vesicles is unknown, the phenomenon implies that cholesterol could be 
sorted for its transport to its destination. 
Second, cholesterol is transported by vesicles. There is some evidence that 
non-vesicular cholesterol transport may be important for maintaining intracellular 
cholesterol distribution. Phillips et al. (1987) and Steck et al. (1988) reported that 
cholesterol can spontaneously move from one membrane to another by a collision 
transfer mechanism, or through the aqueous phase with half-times as low as 1–2 h. 
Soluble sterol-binding proteins may facilitate this process to increase the 
transportation rate.  
Fourth, the affinity of cholesterol with other lipids, especially sphingolipids, 
contributes to its intracellular distribution (Meer, 1989; Holthuis et al., 2001). 
Because of the high affinity between cholesterol and sphingolipids, changes in 
sphingolipid distribution often lead to changes in intracellular cholesterol distribution 
(Slotte, 1997; Puri et al., 1999). 
In the next several sections, the mechanisms of intracellular cholesterol transport 
will be discussed. Before that, the central role of ER should be emphasized. It is 
known that many enzymes involved in cholesterol metabolism, including cholesterol 
and cholesteryl ester synthesis enzymes and regulators, are located in the ER 
membrane. Moreover, the concentration of cholesterol is the lowest in the secretary 
pathway. As mentioned above, Insigs and SSD in HMGR and SCAP endow ER a 
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cholesterol-sensing mechanism. Thus, the ER becomes a pivot to discuss cholesterol 
transport, including input and output.  
The secretory proteins are transported from the ER to the PM via Golgi. Is 
cholesterol in the ER transported through this pathway? Brefeldin A is a drug that 
disassembles the Golgi complex and blocks intracellular transport of secretory 
proteins (Misumi et al.,1986; Doms et al., 1989; Lippincott-Schwartz et al., 1989). 
The delivery rate of newly synthesized cholesterol from the ER to the PM however, is 
decreased only 20% in brefeldin A treated cells (Urbani and Simoni, 1990). This 
vesicle cholesterol transport pathway seems to be a minor pathway. Thus, at least, a 
portion of newly synthesized cholesterol in the ER could be transported to the PM by 
a pathway without participation of the Golgi complex. There may be three other 
mechanisms for this pathway: vesicle transport bypassing the Golgi complex, direct 
translocation at close contact sites of the ER and the PM membranes, and soluble 
sterol-binding protein transport. 
Cholesterol transport from the ER to the PM is ATP dependent (DeGrella and 
Simoni, 1982). Low temperature, such as 15°C, can partially inhibit the movement 
(Kaplan and Simoni, 1985). Some lipid-rich intermediate fraction was found under 
this condition (Heino et al., 2000). These results support the vesicle transport 
hypothesis. 
At some sites, the ER and the PM are in close contact with each other (Putney, 
1999). So far, no direct evidence supports that cholesterol moves at the sites of ER 
and PM interaction. However, some clues indicate that it is possible. At least, close 
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membrane contact appears to be necessary for phospholipid transport between the ER 
and mitochondrial membranes (Shiao et al., 1998; Achleitner et al., 1999). It remains 
to be understood whether some specific proteins are involved in this process. 
Cholesterol transport between the ER and the PM may also use the same mechanism. 
Some sterol binding proteins in the cytosol may facilitate this process, such as sterol 
carrier protein 2 (SCP2) and caveolins. SCP2 may not be limiting for this transport 
since it only affects the transfer rate in the first 10 minutes (Puglielli et al., 1996). 
It is known that the caveolin protein family, including caveolin-1 
(VIP21/caveolin), caveolin-2, and caveolin-3 (Mcaveolin) is related to cholesterol 
binding and transport from the ER to the PM (Parton, 1996; Okamoto et al., 1998). 
Caveolins are a group of small membrane proteins comprising an intramembrane 
loop of 33 amino acid residues. These proteins are hairpin-like in topology. There is a 
conserved ‘scaffolding’ domain at their N-terminus, which could interact with 
signaling proteins. The C-terminus of caveolin-1 is covalently linked with palmitate 
(Ikonen and Parton, 2000). Caveolin-1 and caveolin-2 are present in most tissues and 
often associate with each other in cells. Caveolin-3 is present primarily in skeletal and 
cardiac muscles (Tang et al., 1996).  
Caveolin-1 can bind with cholesterol in the ratio of 1:1 (Murata et al., 1995). 
Smart et al. (1996) and Uittenbogaard et al. (1998, 2000) reported that cholesterol 
may be transported from the ER to the PM by a soluble complex, which contains 
caveolins, heat-shock protein 56, cyclophilin A, and cyclophilin 40. In the total pool 
of caveolin-1, only a small part takes part in cholesterol transport. 
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The study of Scheel et al. (1999) on C. elegans caveolins indicated that 
cholesterol and caveolin together are closely related to signal transduction. Depletion 
of cholesterol or blocked expression of caveolin led to identical phenotypes, an 
altered meiotic cell cycle progression. Caveolin also plays a key role in growth and 
cell adhesion. These functions are also cholesterol dependent. Bist et al. (1997) 
showed that caveolin-1 expression is positively regulated by cholesterol levels 
through sterol-response elements (SREs). 
With the major structural proteins, the caveolins, and highly enriched cholesterol, 
specific region of the PM invaginate to form caveolae, which constitute a 
morphologically distinct membrane domain (Simons and Toomre, 2000). This region 
is also enriched in sphingomyelin, ceramide, phosphatidic acid and phosphoinositides 
(Brown and Waneck, 1992; Liu and Anderson, 1995; Pike and Casey, 1996). The 
formation and density of caveolae are closely dependent on the cholesterol 
concentration in the PM (Rothberg et al., 1992; Hailstones et al., 1998). Caveolae are 
sensitive to changes in cholesterol levels. They disappear when cholesterol is depleted 
from the PM and reappears when cholesterol levels are normal.  
Caveolae are involved in intracellular translocation not only of de novo 
synthesized and recycling cholesterol, but also efflux of cholesterol to the 
extracellular medium (Lange et al., 1997; Underwood et al., 1998). Interestingly, mice 
survive even with a lack of both caveolin-1 and caveolin-2 (Drab and Razani, 2001). 
It was proposed that other pathways exist to transport cholesterol that do not require 
caveolins. The functions of caveolins and caveolae in the cholesterol trafficking 
                                                                                   - 55 - 
remains to be further elucidated. 
Based on the above results, it is not known if non-vesicle transport is the main 
pathway for cholesterol trafficking from the ER to the PM, but it is obvious that some 
pathways without participation of the Golgi complex can handle most of newly 
synthesized cholesterol.  
Sometimes, cholesterol needs to be oxidized in the matrix space of mitochondria. 
The reaction is necessary in pregnenolone and bile acid synthesis. In mitochondria, 
cholesterol can be converted to pregnenolone by the side chain cleavage enzyme 
system (P450scc) (Sugawara and Fujimoto, 2004).  
In order to reach the oxidative machinery, cholesterol is transported to the outer 
membrane of mitochondria by a cytoplasmic cholesterol transfer protein, SCP2, and 
the cytoskeleton, including microtubules, microfilaments and intermediate filaments 
(Stocco, 1998).  
To pass the hydrophilic intra-membrane space between outer and inner 
mitochondrial membranes, a carrier, steroidogenesis acute regulatory protein (StAR), 
plays a crucial role in cholestrol transport (Clark et al., 1994). The transport of 
cholesterol across the mitochondrial membranes takes less than minutes, which is the 
rate-limiting step in the synthesis of steroid hormones (Lin et al., 1995) and an 
alternative bile acids synthesis pathway (Pandak et al., 2002). Kallen et al. (1998) 
showed that only StAR is essential to function as a cholesterol translocation protein 
between mitochondrial membranes.  
Loss of StAR function causes the autosomal recessive genetic disease, congenital 
                                                                                   - 56 - 
lipoid adrenal hyperplasia. The syndrome of this disease is a great impairment in 
gonadal and adrenal steroid hormone synthesis (Stocco, 1998). 
At present, four proteins in the SCP2 gene family, such as SCP2, Sterol Carrier 
Protein X (SCPx), D-peroxisomal bifunctional enzyme (D-PBE) and UNC-24/hSLP-1, 
are known. Their common structural feature is a SCP2 like domain.  
Among them, SCP2, a 123 amino acid small protein, was shown to deliver 
cholesterol from lipid droplets to mitochondria (Chanderbhan et al., 1982). Half of it 
localizes in peroxisomes. The SCP2 like domain is necessary to target D-PBE to 
peroxisomes and confers similar cholesterol transfer activity to this enzyme (Seedorf 
et al., 1995). SCP2 deletion mice are impaired in cholesterol degradation in bile acid 
synthesis (Kannenberg et al., 1999). In fibroblasts treated with SCP2 antisense 
oligonucleotides, the transport of de novo synthesized cholesterol to bile is slower 
than in normal cells (Puglielli et al., 1995). SCPx functions as lipids transfer protein 
to mediate transport of bile acid precursors (α, 7α, 
12α-trihydroxy-24-ketocholestanoyl-CoA) to peroxisomes (Seedorf et al., 1994).  
Caveolins and StAR may be also involved in this transport pathway. Caveolins 
were found to coat lipid droplets (Meer, 2001). In addition, StAR interacts with 
neutral cholesteryl ester hydrolase (nCEH) in lipid droplets (Shen et al., 2003). It may 
stimulate cholesteryl ester hydrolysis and transport the free cholesterol to 
mitochondria for steroidogenesis. 
Neufeld et al. (1996) believes that there are both PM-dependent and 
PM-independent pathways to transport cholesterol in the endosome/lysosome system 
                                                                                   - 57 - 
to the ER. They suggest that the pathway via PM is responsible for the main part of 
cholesterol translocation to the ER. The Golgi apparatus likely mediates this process. 
In NPC1 cells, the transport of cholesterol from endosomes to the PM is defective 
because of abnormal transport of cholesterol to the Golgi apparatus.  
The pathway of direct cholesterol transport from the endosome to the ER is 
considered as the minor pathway. Its mechanism remains to be investigated.  
In addition, recent studies show that overexpression of Rab11, a small GTPase, 
results in accumulation of cholesterol in Rab11-residing vesicles. Biochemically, 
overexpression of Rab11 inhibits the recycling of cholesterol from recycling 
endosomes to the PM and also inhibits cholesterol esterification (Holtta-Vuori et al., 
2002). The detailed mechanism on this phenomenon remains further investigation. 
 
Several mechanisms are involved in the transport of cholesterol from the PM to 
the ER. One is via the LDL endocytosis pathway. This vesicle transport pathway 
requires two proteins in late endosomes and lysosomes, NPC1 and NPC2, localized to 
the late endosome/ lysosome system. They will be discussed later.  
Another potential mechanism of cholesterol transport from the PM to the ER is a 
direct process without participation of endocytosis. This pathway remains to be 
clarified. 
The other mechanism involves liver fatty acid binding protein (L-FABP). L-FABP 
is abundant (3-5%) in liver and in the cytosol of intestinal enterocytes (McArthur et 
al., 1999). L-FABP binds to a broad range of hydrophobic ligands (Hubbell et al., 
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1994; Frolov et al., 1997), including cholesterol (Rustow et al., 1982) and bile acids 
(Thumser and Wilton, 1996; Dietrich et al., 1995). In vitro binding assays with sterol 
added in micellar/monomeric form showed that native rat liver L-FABP binds sterols 
with dissociation constants near 0.3μM and 1:1 molar stoichiometry (Schroeder et al., 
1998). L-FABP selectively enhances intermembrane cholesterol transfer from isolated 
plasma membranes to isolated mitochondria in vitro (Frolov et al., 1996). Moreover, 
L-FABP enhances cholesterol uptake, cholesterol transport from the PM to the ER for 
cholesterol esterification (Jefferson et al., 1991). The cholesterol binding domain of 
L-FABP is essential for its intermembrane sterol transfer activity. 
SCP2, L-FABP, caveolin and StAR are sterol binding proteins (Schroeder et al., 
2001). The physiological significance and mechanism on how these sterol binding 
proteins enhance intracellular sterol trafficking cannot be clearly resolved without 
adequate knowledge of the intracellular localization of these proteins. There is general 
agreement on the intracellular localization of several of the sterol binding proteins. 
For example, subcellular fractionation and immunocytochemical studies of bovine 
and rat indicate that the highest concentration of L-FABP is found in the cytosolic 
fraction, but significant amounts are associated with mitochondria, microsomes and 
nuclei (Bordewick et al., 1989). As indicated above, caveolin is localized to the 
cytoplasmic face of PM caveolae, the trans-Golgi and cytosol. StAR rapidly 
translocates from the endoplasmic reticulum to mitochondria (Stocco, 1998; Lin et al., 
1995).  
Not consistent with its qualitative assessment of immunocytochemical and 
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subcellular fractionation data, a quantitative assessment of SCP2 clearly shows that 
nearly half of the 13 KDa protein is extra-peroxisomal. Although the organellar 
concentration of SCP2 is highest in peroxisomes, the peroxisomes account for only 
2.5% of liver protein (Tsuneoka et al., 1988) and 0.66% of typical cell volume 
(Mendis-Handagama et al., 1992). In contrast, although the concentration of SCP2 in 
liver cytosol is 17-fold lower than in peroxisomes, cytosol accounts for 35% of cell 
protein and consequently total SCP2 in cytosol is nearly equivalent to the amount in 
peroxisomes (Tsuneoka et al., 1988). 
Figure 1.3 illustrates the pathways of intracellular cholesterol transport and the 
proteins involved. 
 
1.3 A Putative Cholesterol Transporter, NPC1 
Presently, the mechanism of cholesterol transport from lysosomes to other 
organelles is still unknown. Niemann-Pick type C disease offers a good genetic model 
to study this protein. The next several sections will review some literature on cell 
biology, including topology, localization, and function of NPC1. 
 
1.3.1 Molecular and Cell Biology of NPC1 
Niemann-Pick type C disease is a serious autosomal recessive disease that causes 
abnormal viscera and central nervous system. Patients are usually normal untill 1 to 2 
years of age. Symptoms appear between years 2 and 4 of age. These children 
gradually develop neurological abnormalities, such as ataxia, grand mal seizures, and 
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loss of previously learned speech. Other symptoms include dystonia, vertical 
supranuclear gaze palsy, dementia, and psychiatric manifestations. Cholestatic 
jaundice occurs in some cases. Foamy Niemann-Pick cells and 'sea-blue' histiocytes 
with distinctive histochemical and ultrastructural appearances are found in the bone 
marrow. Death usually occurs between the age of 5 to 15 (Brady, 1983; Patterson et 
al., 2001).  
 
1.3.2 The Pathogenicityof NPC Disease 
The first pathological factor of NPC disease, NPC1, was identified by Carstea et 
al. (1997). It will be discussed later and it is also the main focus of this thesis. Another 
factor, NPC2/HE1, was identified by Naureckiene et al. (2000). NPC2 encodes a 
soluble, 151-amino acid lysosomal protein. It can bind cholesterol (Kd = 2.3μM) with 
a 1:1 stoichiometry (Naureckiene et al., 2000; Okamura et al., 1999). Three small 
hydrophobic cavities in this protein together form a cholesterol-binding site. This 
hydrophobic region involves tyrosine-100 and phenylalanine-66 (Friedland et al., 
2003).  
Among all NPC cases, 95% cases attribute to NPC1 mutations, while NPC2 
mutations are responsible for the rest 5% cases. Mouse models with defined mutations, 
including npc1, npc2 or npc1 npc2 double mutations, have been developed, named as 
NPC1, NPC2 and NPC1:NPC2 mouse, respectively. These mice developed very 
similar clinical phenotypes to those of human NPC patients (Chang et al., 2005). 
Cholesterol starts to accumulate in NPC1 mouse brain at the 9th postnatal day (PND) 
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(Reid, 2004). Clinical symptoms develop at the 7th week (Xie et al., 2000). At the 
10-12th week, most of NPC1 mice die (Chang et al., 2005). 
At present, it is not clear how NPC1 and NPC2 fuction in cholesterol transport. 
 
1.3.3. The Gene and Localization of NPC1 Protein 
Carstea et al. (1997) cloned the NPC1 gene and found that it encodes a 1278 
amino-acid protein. So far, more than 170 mutations through the entire gene in NPC 
patients have been identified (Carstea et al., 1997; Yamamoto et al., 1999, 2000; 
Millat et al., 1999, 2001; Greer et al., 1998, 1999; Sun et al., 2001; Bauer et al., 2002; 
Park et al., 2003).  
NPC1 is a membrane glycoprotein and localized to LAMP2+ organelles, 
presumably late endosomes and lysosomes (Higgins et al., 1999). NPC1 can be 
detected on both limiting and internal membranes of late endosomes. Interestingly, 
the results of Neufeld et al. (1999) showed that NPC1 does not colocalize with 
another late endosome marker, mannose-6-phosphate receptor (MPR). They 
demonstrated that NPC1 resided primarily in late endosomes and only transiently in 
lysosomes and the trans-Golgi network (TGN). Results from fluorescence microscopy 
revealed that NPC1-GFP trafficks rapidly to and from these compartments in tubules 
and vesicles by a process that requires microtubules (Ko et al., 2001; Zhang et al. 
2001). This dynamic process is regulated by cholesterol (Zhang et al., 2001; Ko et al., 
2001). 
In monkey brain, NPC1 is mainly expressed in astrocytic glial processes closely 
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associating with synapses (Patel et al., 1999). This site is just the earliest site where 
degeneration occurs in NPC patients. 
 
1.3.4. The Topology of NPC1 
Accumulated evidence provides a sketch for topological construction of the NPC1. 
It includes 13 transmembrane domains and 3 large lumenal loops (Davies et al., 2000). 
To prevent digestion by endosomal and lysosomal proteases, the loops are highly 
glycosylated (Watari et al., 1999; Davies et al., 2000).  
The most predominant part of this protein is a conserved five-consecutive 
transmembrane domain (III-VII), SSD (Davies and Ioannou, 2000). Single mutations 
in this region, such as Y635C and the P692S, result in the functional loss of NPC1 
(Watari et al., 1999; Ko et al., 2001). The fluorescent protein-tagged NPC1 (FP-NPC1) 
directly interacts with a photoactivatable cholesterol analog, 
7,7-azo-5α-cholestan-3α[3H]-3β-ol ([3H]-AC), which has very similar metabolic 
properties to [3H]-cholesterol (Ohgami et al., 2004). No interaction has been observed 
between [3H]-AC and the Y635C or the P692S mutants. These studies indicate that 
the SSD may play an important role in the function of NPC1. In addition, another 
conserved region (amino acid residues 55-165) termed “NPC1 domain”, is present at 
the N-terminal end of all NPC1 orthologs, (Carstea et al., 1997; Loftus et al., 1997). It 
includes a leucine zipper motif (amino acid residues 73–94), a putative structure to 
mediate homo- or hetero-dimerization (Ramsdale et al., 1996; Tong et al., 1997). 
Mutation of conserved cysteine residues to serine in this domain leads to a functional 
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loss of NPC1 (Watari et al., 1999). The structure of NPC1 is shown in figure 1.4.  
 
1.3.5. Function of NPC1 
Gilbert et al. (1981) showed that there are higher levels of sphingomyelin and 
ganglioside in liver, spleen and the central nervous system of some NPC1 cases as 
compared to normal tissues. Subsequently, Pentchev et al. (1985) found that unlike 
type A and type B Niemann-Pick, all 20 available Niemann-Pick type C cell lines are 
defective in the rate of cholesterol esterification by in vivo assay. The findings of 
Vanier et al. (1988) confirmed that cholesterol esterification is prominently deficient 
in homozygous NPC1 cells, whereas intermediately deficient in heterozygous cells. 
Besides sphingolipids and cholesterol, NPC1 mutant cells also accumulate other 
compounds in a tissue specific manner, including phospholipids, sphingoid bases, 
cysteine, glycosphingolipids, glycoproteins (Patterson et al., 1999) and sucrose 
(Kobayashi et al., 1999) in lysosomes.  
However, recent studies show that NPC1 may play a primary role in cholesterol 
transport. The data of Thomas et al. (1989) showed that by depleting cholesterol by 
removing lipoproteins from the medium results in correction of sphingomyelinase 
deficiency of NPC1, which is on average only about 37.9% of the activity in normal 
cells. In addition, Salvioli et al. (2004) found that depletion of cholesterol corrected 
mislocalization of glucosylceramidase in NPC1 cells. Furthermore, Cruz and Chang 
(2000) reported that although N-butyldeoxynojirimycin (NB-DNJ) can deplete 
glycosphingolipids from NPC1 cell, the drug does not affect cholesterol biosynthesis 
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and also does not restore defects in endogeneous cholesterol esterification. All these 
results collectively show that accumulation of cholesterol may be the primary factor 
to induce NPC disease. The accumulation of sphingolipids may be a consequence of 
its high affinity to cholesterol. 
The dye, filipin, has high affinity to unesterified cholesterol, which was used to 
demonstrate the distribution of cholesterol in the cell. Filipin staining showed that 
more cholesterol accumulated in NPC cells than the wild type when incubated with 
LDL (Pentchev et al., 1985). However, further investigations show that LDL uptake, 
lysosomal processing and even in vitro ACAT activity is normal in NPC cells.  
Contrast to normal cells, loaded LDL-derived cholesterol in NPC cells cannot 
up-regulate cholesterol esterification and down-regulate cholesterol synthesis and 
LDL receptor activity (Pentchev et al., 1985; Liscum and Faust, 1987). LDL derived 
cholesterol was more difficult to replenish the cholesterol pool of PM in NPC cells 
than that in normal cells (Sokol et al., 1988). 
Based on the above observations, NPC1 is proposed to play a role in intracellular 
cholesterol transport. NPC1 is not required for transportation of de novo synthesized 
cholesterol from the ER to the PM via the Golgi (Liscum and Faust, 1989). Strikingly, 
unesterified cholesterol derived from LDL is accumulated in lysosomes of NPC cells 
(Pentchev et al., 1987; Liscum et al., 1989). This results in a defect of exogenous 
cholesterol esterification (Cruz and Chang, 2000). Although de novo cholesterol 
transport from the ER to the PM is not affected by NPC1 mutations, after 
redistribution in the cell, less de novo cholesterol returns to the ER from the PM (Cruz 
                                                                                   - 67 - 
and Chang, 2000). However, it takes a longer time to display obvious defects in 
endogenous cholesterol transport than in LDL-derived cholesterol transport. This 
phenotype is present in all tested NPC homozygous cell types, including embryonic 
fibroblasts, hepatocytes, and especially prominent in peritoneal macrophages and 
cerebellar glial cells (Reid et al., 2003). Thus, NPC1 is also involved in endogenous 
cholesterol transport from the PM to the ER. Recent studies showed that 
overexpression of the small Rab GTPases, including Rab7 and Rab9, corrects the 
cholesterol accumulation phenotype in NPC cells (Choudhury et al., 2002). 
In addition, excessive cholesterol derived from LDL is accumulated not only in 
lysosomes of NPC cells, but also in the Golgi complex (Blanchette-Mackie et al., 
1988). This suggests that the Golgi complex may be involved in exogenous 
cholesterol transport in cells. 
The NPC1 gene was expressed in E. coli (Davies et al., 2000), and the gene 
product localized to the PM. In E. coli, NPC1 transports fatty acids by proton motive 
force rather than cholesterol or cholesteryl ester across the PM. This may be because 
no necessary accessory proteins or mammalian specific cholesterol acceptors are 
available in E. coli, or that NPC1 does in fact not transport cholesterol (Scott and 
Ioannou, 2004). 
Class 2 amphiphiles, such as trifluoperazine, imipramine and U18666A, can 
inhibit post-lysosomal cholesterol transport and treated cells display a similar 
cholesterol accumulation as NPC cells (Roff et al., 1991). Among these compounds, 
sphinganine may be the endogenous factor which contributes to the cholesterol 
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transport defect in NPC cells. 
 
1.3.6. The Effect of NPC1 in Brain 
The ultimate cause of death in NPC disease is progressive neurological 
deterioration in the central nervous system. In mammals, the brain contains more 
unesterified cholesterol than any other organ in the body (Dietschy and Turley, 2004). 
The major cholesterol source of brain is endogenous synthesis (Cruz and Chang, 
2000). Another source is exogenous cholesterol from plasma crossing the brain blood 
barrier. Although the main cholesterol source is endogenous, nerve cells from NPC 
patients also accumulate excessive cholesterol. Evidence shows that trafficking of 
both exogenous and endogeous cholesterol is deficient in NPC neurons and astrocytes 
(Reid et al., 2003; Karten et al., 2002, 2003). 
Like in NPC fibroblasts, esterification of LDL derived cholesterol in embryonic 
striatal neurons from npcnih mice is significantly defective (Henderson et al., 2000). 
This defect results in loss of TrkB function and brain-derived neurotrophic factor 
(BDNF) response failure. 
Unlike in other types of Niemann-Pick diseases, NPC neuron cells present 
neurofibrillary tangles, which are also found in Alzheimer’s disease, another known 
neuro-degenerative disease. The paired helical filament tau (PHFtau) protein in brain 
tissue from Niemann-Pick type C patients is similar to PHFtau of Alzheimer patients 
(Auer et al., 1995).  
In addition, NPC1 mutations combined with homozygous ApoE4 defects lead to 
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similar pathological phenotypes as in Alzheimer’s disease, including abundant 
neurofibrillary tangles, PHFtau accumulation and widespread increased beta-amyloid 
diffuse plaques (Saito et al., 2002). 
 
1.3.7 Mutant Proteins which Produce NPC-like Phenotypes 
Mutations in several other proteins also cause NPC-like defects. MLN64 is a late 
endosomal/lysosomal membrane protein with a START domain (Alpy et al., 2001). It 
may function as a shuttle carrier of cholesterol. In cultured cells, overexpression of a 
truncated MNL64 lacking the START domain, or of its homologue, MENTHO that 
naturally lacks a START domain, results in an NPC-like endosomal cholesterol 
accumulation (Zhang et al., 2002; Alpy et al., 2002).  
Mutations in 3β-hydroxysteroid Δ7-reductase gene (DHCR7) leads to a defective 
degradation of LDL and accumulation of LDL-derived cholesterol in cells (Wassif et 
al., 2002). These mutations can cause RSH/Smith-Lemli-Opitz syndrome (SLOS). 
The exact mechanism of the two proteins on cholesterol transport remains to be 
elucidated. 
 
1.4 The Advantages of Studying Human Disease Using S. cerevisiae as a Model. 
The research reviewed above was based upon mammalian cells. However, this 
study used Saccharomyces cerevisiae as a model because of its unique characteristics. 
In order to study NPC1, S. cerevisiae, is used as a model because of the following 
reasons. First of all, Culturing of S. cerevisiae is easy and fast. S. cerevisiae is a 
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eukaryotic single-cell organism with all kinds of organelles. Thus, compared to 
mammalian cells, it possesses great homology in genes, similar cell structure and 
biochemical pathways but the organism is simple to handle experimentally. S. 
cerevisiae possesses a very large organelle named vacuole, which is the functional 
counterpart of mammalian lysosomes. It is a distinct structure under the microscope 
because of its prominent size.  
Its genome has been fully sequenced. Unlike other eukaryotic cells, few of its 
genes contain introns. All genome information can be obtained from the database, 
http://www.yeastgenome.org/.  
Another advantage is that S. cerevisiae encodes some powerful recombinases, 
such as Rad51p and Flp. Maybe due to these enzymes, DNA recombination occurs 
more easily in S. cerevisiae than in most other eukaryotic cells. It only takes one week 
to disrupt a gene in S. cerevisiae, as compared to one to two months to knockout one 
gene in cultured cells, and 6 months to one year in mice.  
In addition, the molecular biology for S. cerevisiae is well developed. numerous 
kinds of vectors are available, thus making yeast genetics easy to study. 
Some research areas have been well developed in S. cerevisiae, such as the 
endocytosis pathway, or many biochemical pathways, including sterol biosynthesis 
and fatty acid biosynthesis. These pathways are highly conserved between yeast and 
human. For example, the main sterol in yeast is ergosterol, however its structure is 
very similar to cholesterol and biosynthesis of these two lipids share many common 
reactions. 
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 1.5 Sterol Homeostasis in Yeast  
The ER is still the critical organelles in yeast sterol homeostasis because it is still 
the place for sterol synthesis (Basson et al., 1985) and sterol esterification (Yang et al., 
1996). Although the main sterol in yeast is ergosterol, physiologically, yeast sterol 
biosynthesis (Basson et al., 1985), regulation (Hampton and Rine, 1994) and 
esterification (Yang et al., 1996) is highly similar to these processes in mammalian 
cells. However, no ortholog of SCAP and SREBP has been found so far. 
Also, no lipoprotein receptor has been found. Uptake of sterol in yeast is poorly 
understand. Aus1p and Pdr11p may be involved in this process. They are belonging to 
ABC transporter family (Henneberry and Sturley, 2005).  
ACAT orthologs in S. cerevisiae, Are1p (ACAT-related enzyme) and Are2p, 
contribute to ergosterol esterification (Yang et al., 1996). Both Are1p and Are2p 
localize to the ER membrane (Zweytick et al., 2000). Deletion of ARE2 alone causes 
an 80% decrease in ergosterol esterification. Although no significant change in 
ergosterol esterification was observed upon disruption of ARE1 alone, deletion of both 
ARE1 and ARE2 genes leads to 95% decrease in ergosterol esterification (Yang et al., 
1996).  
The specific substrate of Are2p is ergosterol. The main specific substrate of Are1p 
is lanosterol as though Are1p can also utilize ergosterol (Zweytick et al., 2000). In 
addition, Are1p is also involved in TAG synthesis (Sandager et al., 2000).  
A novel gene, ARV1 (ARE2 required for viability), has recently been identified in 
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S. cerevisiae (Tinkelenberg et al., 2000). Arv1p localizes to the ER and the Golgi 
membranes (Swain et al., 2002). It may function to transport ergosterol from the ER 
to the PM (Tinkelenberg et al., 2000). 
ARV1 is required for viability in the absence of the ARE2 gene. It is also required 
for ergosterol uptake and distribution in cells. As compared to wild type, deletion of 
ARV1 significantly elevates ergosterol levels in the ER and vacuole membranes and 
decreases the ergosterol level in the PM. Perhaps due to the high affinity between 
sterol and sphingolipids, deletion of ARV1 also affects the distribution and 
metabolism of sphingolipids (Swain et al., 2002). 
 
1.6 Ncr1p, the Ortholog of NPC1 in S.cerevisiae 
NCR1 (YPL006w) (NPC1 related gene 1) is a yeast orthologue of mammalian 
NPC1. It is 35% identical to the human NPC1 gene. Yeast NCR1 can complement the 
function of NPC1 in a CHO NPC1 deletion strain. The gene product is an 1170 amino 
acid residue transmembrane protein. A dominant mutation Y718D, rather than ncr1Δ, 
a complete deletion, changes the metabolism of sphingolipids (Malathi et al., 2004). It 
elevates the level of MIPC and decreases the levels of IPC and M(IP)2C. This 
dominant mutation also causes MIPC and M(IP)2C to accumulate in the vacuole. 
However, this mutation and NCR1 deletion do not change the intracellular distribution 
of ergosterol. 
 
1.6 Objectives and Significance of this Study 
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The distribution of sterol among organelles in S. cerevisiae is similar to that of 
higher eukaryotes (Zinser et al., 1993; 1995) and this budding yeast is a good model 
to study sterol homeostasis and trafficking (Sturley, 1998). 
Mammalian cells acquire cholesterol through exogenous uptake, mainly from low 
density lipoprotein (LDL), and endogenous synthesis. The biochemical hallmark of 
NPC mutant cells is the defect in transport of both low density lipoprotein 
(LDL)-derived cholesterol in the endosomal/lysosomal system and of endogenous 
cholesterol. However, in spite of the striking evolutionary conservation on DNA 
sequence between NCR1 and NPC1, no significant difference in ergosterol 
esterification and biosynthesis is detected in yeast ncr1Δ cells (Sturley, 2000). This 
could be explained by the fact that the budding yeast does not take up ergosterol from 
its environment during aerobic growth. Alternatively, the normal ergosterol 
metabolism in ncr1Δ strain may result from the movement of only a small amount of 
endogenous ergosterol between subcellular organelles, especially movement into and 
out of the vacuole, under laboratory growth conditions. This amount of ergosterol 
may be insufficient to generate a detectable phenotype.  
One of the important aims of this study was to address the latter possibility. A 
variety of conditions were tested, but even under these conditions, deletion of NCR1 
gene alone did not affect ergosterol esterification. We hypothesized that there would 
be a synergestic effect among Ncr1p and ergosterol esterification enzymes, Are1p and 
Are2p. The genes involved in the synergistic effect can at least partially compensate 
their function to each other. Deletion of two or more of the components would induce 
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a much more serious effect than deletion of only one of them. 
The principal purpose of this study was to investigate the pathway of intracellular 
ergosterol transport in S. cerevisiae. The specific aims of this research were: 
1) To determine the location and trafficking of Ncr1p. Sucrose density gradient 
centrifugation was used to separate the fractions containing different organelles. 
Fluorescence microscopy was used to observe GFP fusion proteins distribution. 
2) To investigate the effect of NCR1 on ergosterol homeostasis. The tritium 
incorporation assay was used to measure the rate of in vivo esterification. 
3) To examine the interaction between Ncr1p and yeast orthologs of Insigs, Nsgs. 
GST pull-down assay was used to detect in vitro protein interaction.  
4) To study the relationship of Ncr1p to the proteins related to ergosterol homeostasis, 
such as Arv1p, Are1p and Are2p. Acute glucose starvation mimicked the natural 
condition under which energy source was exhausted. This study investigated roles 
of Ncr1p under these conditions. 
 
Using S. cerevisiae, the relationship between Ncr1p and Nsgs, Arv1p and Ares 
was investigated. The role of Ncr1p in ergosterol uptake and efflux was not 
investigated due to the fact that ergosterol uptake and efflux may not be significant 
during aerobic growth and the two processes are not very clear yet. 
These studies is expected to help us understand the basic concept of intracellular 
ergosterol transport. In addition, information about the relationship of Ncr1p to the 
proteins related to ergosterol homeostasis would shed light on the mechanism of NPC 
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disease. Moreover, the mechanism of NPC disease may give some clues to understand 
the pathology of neurondegeneration diseases and their potential treatment. The 
findings of this investigation may provide evidence for the evolution of cholesterol 
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Chapter 2 Materials and Methods 
2.1 Strains, Media and Materials 
The S. cerevisiae strains used in these studies are listed in Table 2. Yeast cells 
were grown on complete (yeast extract, peptone and dextrose) or synthetic medium. 
Complete media (YPD) are composed of 1%yeast extract (Y), 2% bactopeptone (P), 
2% dextrose (D). The component of synthetic media (SD) is 0.67% yeast nitrogen 
base with ammonium sulfate (YNB), 2% dextrose (D) and supplements. All solid 
media contained 2% agar. The component of media YP (yeast extract and peptone) is 
similar with YPD but without dextrose (D). Transformation of yeast was performed as 
described (Adams et al., 1997).  
Yeast extract, Yeast Nitrogen Base, Bactopeptone and Bacto-agar were from Difco 
laboratories (Detroit, MI). D-dextrose, lyticase and horseradish peroxidase conjugated 
secondary antibodies were from Sigma (St. Louis, MO). Zymolyase-20T was from 
US Biologicals (Swampscott, MA). [9, 10(n) - 3H] oleic acid and [1-14C] oleoyl CoA 
were from Amersham Biosciences (Pittsburgh, PA). Protease inhibitors were from 
Sigma and were added at the following final concentrations: 10mg/ml aprotinin, 
5mg/ml leupeptin, 8mg/mL pepstatin A, 1mM PMSF.  
Rabbit polyclonal α-hexokinase antibody was from Rockland (Gilbertsville, PA); 
α-Dpm1p, α-ALP1, α-Vph1p and α-Pep12p from Molecular Probes Inc. (Eugene, OR), 
α-Gas1p rabbit polyclonal antibodies from H. Riezman (Biozentrum, University of 
Basel, Switzerland) and Tlg1 antibody from W. Hong (Institute of Molecular and Cell 
Biology, Singapore) 
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Table2. Strains used in this study 
Strain Relevant genotype Reference 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Euroscarf 
Y02822 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YPL006w׃׃KanMX4 Euroscarf 
Y02362 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YOR106w::KanMX4 Euroscarf 
Y07174 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YBR288c::KanMX4 Euroscarf 
Y01812 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YOR036w׃׃KanMX4 Euroscarf 
Y04462 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
YGL095c::KanMX4 Euroscarf 
Y11969 
BY4742; MATα; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; 
YNL243w::kanMX4  Euroscarf 
Y05381 
BY4741; MATa; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; 
YNR006w::kanMX4  Euroscarf 
Y05072 
BY4741; MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; 
YKR001c::kanMX4  Euroscarf 
Y05588 
BY4741; MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; 
YPR173c::kanMX4  Euroscarf 
Y01709 
BY4741; MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; 
YOL018c::kanMX4  Euroscarf 
RH1372 MATa sec1Δ ura3Δ leu2Δ his4Δ lys2Δ barΔ H.Riezman 
RH2043 
MATa sec18Δ pep4Δ::URA3 ura3Δ leu2Δ his4Δ lys2Δ 
barΔ H.Riezman 




MATa, can1-100, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, 
are1ΔNA::HIS3, are2Δ::LEU2 
Yang et al., 
1997 
SCY060 
MATα, can1-100, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, 
ade2-1, are1ΔNA::HIS3 
Yang et al., 
1997 
SCY061 
MATa, can1-100, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, 
are2Δ::LEU2 
Yang et al., 
1997 
SCY062 
MATα, can1-100, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, 
ade2-1 
Yang et al., 
1997 
W303 
MATα, leu2-3, 112 his3-11, 15 ade2-1 ura3-1 trp1-1 
can1-1 RAD5  
SZY001 SCY062, ncr1Δ::klURA3 This study 
SZY002 SCY060, ncr1Δ::klURA3 This study 
SZY003 SCY061, ncr1Δ::klURA3 This study 
SZY004 SCY059, ncr1Δ::klURA3 This study 
SZY005 
MATα, leu2-3, 112 his3-11, 15 ade2-1 ura3-1 trp1-1 
can1-1 RAD5, ncr1Δ::HIS3 This study 
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 2.2 Production of Antisera Against Ncr1p  
2.2.1 Expression of an 189 aa Ncr1p Polypeptide  
The DNA sequence encoding amino acid residues 807-995 of Ncr1p was 
amplified by PCR using the following primers: NCR-35 (5' 
GCGAGCTCAAGAATTTAGATTTGACTA 3') 
NCR-33 (5' CCCAAGCTTAGTTTGATATTGAACAAAA 3'). The PCR product was 
digested by XhoI and HindIII and ligated into pQE30 (Qiagen, Valencia, CA). The 
gene encoding a 189 amino acid residues polypeptide was induced with 0.5mM IPTG 
at OD600=0.6 in E. coli M15. After 4 hours induction, cells were precipitated and 
proteins extracted. 
 
2.2.2 Purification of 189aa Ncr1p Peptides Using Talon® Beads (Clontech, Palo 
Alto, CA) 
• The cell pellet from 250ml culture was washed with H2O and lysed with 25ml 
lysis buffer (50mM Na2HPO4, pH 8.0, 0.3M NaCl, 8M urea and protease 
inhibitors). The lysate was sonicated on ice for 3×15sec and followed by a 
3000×g centrifugation for 5 mins. 
• 500μl Talon® beads were added to the supernatant and incubated at 4°C for 1 
hour. 
• After 3000×g centrifugation, the supernatant was removed. The beads were 
washed with 5ml washing buffer (8M Urea, 50mM Na2HPO4, pH 8.0, 0.5M 
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NaCl and protease inhibitors), and centrifuged at 3000×g for 5mins. This 
procedure was repeated twice. 
• 1ml washing buffer including 20mM imidazole was added to beads and 
incubated for 1 hour. The beads were precipitated at 3000×g for 5mins. This 
procedure was repeated twice. 
• 1ml elution buffer (8M urea, 20mM Tris pH 7.5, 100mM NaCl) including 
200mM imidazole was added to beads and incubated for 1 hour. The beads 
were precipitated at 3000×g for 5mins and the supernatant was transferred to 
another clean tube. This procedure was repeated five times. 
 
2.2.3 Electro-elution to Purify the Peptide (From TY Chang, private 
communication) 
• The peptide which was purified by Talon® beads was separated by preparative 
SDS-PAGE. After electrophoresis, the gel was soaked in H2O for 10 minutes. 
• The gel was transferred to 0.25M KCl for 5 minutes and then transferred to 
H2O. 
• The gel was examined periodically to determine if the bands could be clearly 
recognized.  
• The expected band was excised and minced.  
• The minced gel was loaded into the Model 422 Electro-Eluter. The 
electro-elution buffer was 0.3% Tris, 1.44% Glycine, and 0.1% SDS.  
• The gel was eluted at 8-10mA/glass tube constant current for 3 to 5 hours.  
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• After elution, the electro-eluter module was removed from the buffer tank. 
Buffer was removed carefully without disturbing the liquid below the frit.  
• The remaining liquid in the membrane cap was collected in a microcentrifuge 
tube.  
• The membrane cap was rinsed with 200µl elution buffer. The rinse solution 
was pooled to the microcentrifuge tube.  
 
The purified peptide was used to immunize two rabbits and the resulting serum 
was used directly for immunoblotting at 1:1000 dilution.   
 
2.3 Characterization of Ncr1p 
2.3.1 Mini Yeast Chromosomal DNA Preparation  
Yeast cells (5 ml in conical tube) were grown overnight. Cells were collected by 
centrifugation at 1000×g/5mins. Cells were resuspended in 1ml H2O and transferred 
to Eppendorf tubes.  H2O was removed after cells were centrifuged at 1000×g for 
5mins. 0.2 ml lysis buffer (2% Triton X-100, 1% SDS, 100mM NaCl, 10mM Tris-Cl, 
pH 8, 1mM EDTA) was added to the cells. 0.2ml phenol: CHCl3 (1:1) and 0.3mg 
glass beads (approx. 100µl volume) were added. Each sample was vortexed at full 
speed for 4mins and then 0.2ml TE buffer was added. Samples were centrifuged at 
13,000 rpm for 5mins. The upper aqueous layer was transferred into a new tube and 
mixed with 100% ethanol and inverted 5-6 times. Samples were centrifuged at 13,000 
rpm and supernatant was removed. DNA was dried and resuspended in 25-40µl TE 
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RNase buffer. 
 
2.3.2 Transformation of S. cerevisiae 
• Cells were grown in 5ml YPD at 30°C overnight and reinoculated into 25ml 
YPD at the second day. 
• Cells were collected at OD600=0.8, washed once with 25ml H2O and 
suspended in 1ml H2O. The cells were always centrifuged at 1000×g for 
3mins. 
• Cells were precipitated. The pellet was suspended in 400μl 100mM LiAc. 
• At the same time, carrier DNA was boiled for 10mins. 
• 50μl LiAc treated cells were centrifuged to remove the supernatant. 
• 240μl 50%PEG4000, 36μl 1M LiAc, 25μl carrier DNA and 50μl plasmids or 
PCR product (including H2O) were added subsequently.  The cells and 
reagents were mixed completely and incubated at 30°C /30 min followed by 
42°C for 20mins. 
• The cells were precipitated. The pellet were resuspended in 200μl YPD and 
plated. The plates ware incubated at 30°C for 2-3 days. 
 
2.3.3 Construction of Plasmids and Gene Disruption 
(a) Construction of plasmids expressing NCR1, NCR1-GFP and NCR1ΔC11: 
To express NCR1, the entire coding sequence of NCR1 including the stop codon plus 
its promoter region (1000 base pairs upstream of the start ATG) was amplified by 
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PCR from S. cerevisiae genomic DNA using the following pairs of primers: Ncr1–5 5' 
aaggaaaaaagcggccgcagctcgaaatccagttta 3', Ncr1–3 5' cagctggccaactagtgc 3'; Ncr2–5 5' 
atggattatagcactagt 3', Ncr2–3 5' atttcccacattcctgcag 3'; Ncr3–5 5' aactgcaggaatgtggga 
3', Ncr3–3 5' ccgctcgagctaatcttctgcttcgatg 3'. The three PCR fragments were 
subcloned sequentially into plasmids YCplac111 and YEplac181 (Gietz and Sugino, 
1988). Both of the plasmids carry LEU2 gene. But YCplac111 contains a yeast single 
copy origin, CEN4 and Yep181 a multiple copy origin, 2 micron. 
To construct NCR1-GFP, the same PCR-mediated procedure was adopted with the 
same primers except for Ncr13–3, which was replaced by Ncr33nostop: 5' 
ccgctcgaggcatcttctgcttcgagt 3'. The GFP coding sequence was introduced in frame at 
the 3' end of NCR1 (Craven et al., 1998).  
(b) For pNCR1ΔC11, Ncr13–3 was replaced by Ncr3–3C: 5' 
ccctcgagctatttcaccaccaaacaatgaaa 3'. The accuracy of all PCR amplifications was 
confirmed by sequencing.  
PCR mediated disruption of NCR1: 
Primers NCR1K5Ura: 5' 
ACTAAATTCATCTCCAAAAAGAACAAGAGCAGAACTTCAATTAGTAAAACC
CATGGCAATTCCCGGGGATCG 3' and NCR1K3Ura: 5' 
AACGAATTTTTACCTATTTTTTCACTACGTAAAATATAGTATAATCTGCTATGC
ATGGTGGTCAGCTGGAATTC 3' were used to produce an NCR1 knock-out 
cassette by PCR, which was used to transform wild type (WT, SCY062), are1Δ 
(SCY061), are2Δ (SCY062) strains to create single or double deletion strains (Erdeniz 
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et al., 1997). 
Another disruption of NCR1 by the HIS3 gene used primers NCRKO-5 5' 
GAGGGGACGAAAATTAGCCGCTATTAATTCTGGTATTGCCACCTAGACAAG
AAGTAAACAGACACAGATGcaagagttcgaatctcttagc 3' and NCRKO-3 5' 
CTATAAAGATTTAATAGCTCCACAGAACAGTTGCAGGATGCCTTAGGGTCG
Actacgtcgtaaggccgtttctgac 3'. The PCR preduct was used to transform the strain W303 
to create the corresponding NCR1 deletion strain (Wach et al., 1997).  
 
2.3.4 Protein Extraction from Yeast Cells 
• Cells were cultured (in respective medium) to OD600=0.8-1.0.  
• The cells were harvested by centrifugation for 2-3 mins at 3000rpm.  
• The pellet was resuspended in 1.5ml stopmix (see below). 
• The cells were transferred to a 2ml eppendorf tube and spun down again (the 
cell pellet can be snap-frozen in liquid  nitrogen at this stage and store at 
–80˚C until further use).  
• The cell pellet were resuspended in 150-200μl cold lysis buffer (see below). 
• Equal or ¾ volume glass beads (Biospec, Inc.) were added and the cells were 
broken in a beads-beater for 30seconds, pausing for 2 mins to cool down then 
another burst for 30seconds.  
• The broken mix was spun at 500×g for 5 mins and the supernatant was 
transferred into a 1.5ml tube.  
• The step was repeated twice. 
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• The total amount of protein was measured.  
Stopmix: 0.9% NaCl, 1mM NaN3, 10mM EDTA, 10mM NaF. Lysis buffer: 
Triton X-100 5ml, 10% SDS 5ml 1M Tris (pH7.2) 25ml, Na-deoxycholic acid 5g, 
Na-orthovanadate 0.0092g, add H2O to 500ml, 100× PMSF (17.42mg in 1ml 100% 
EtOH), 1000× LA (2mg/ml leupeptin and 4mg/ml aprotinin). 
 
2.3.5 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
and Immunoblotting Analysis  
Denaturing gel electrophoresis was performed using 10% polyacrylamide for the 
resolving gel in the presence of 0.1% sodium dodecyl sulfate (Laemmli, 1970).  
After SDS-PAGE separation, the proteins were electro-blotted to nitrocellulose.  The 
membrane was blocked in 5% non-fat milk in 20mM Tris-HCl, 137mM NaCl and 
0.1% Tween-20 (TBST) and probed with antibody (Chang et al., 1995) in TBST 
non-fat milk for 2 hours.  Detection of the immune complexes was attained using 
horse radish peroxidase-conjugated secondary anti-rabbit or anti-mouse IgG antibody 
and the SuperSignal Western Pico Blotting Detection Reagent (PIERCE).   
 
2.3.6 Visualization of Ncr1p-GFP 
NCR1 knockout cells, Y02822, transformed with plasmids constitutively 
expressing NCR1-GFP were grown to early log phase at 30oC in SD media, washed 
and used directly for fluorescence microscopy.   
For temperature shift experiments, cells were grown at 23oC until early log phase 
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and then incubated at either 34oC (sec1 and sec18) or 38oC (sec7, vps4, end4) for 
ninety minutes prior to fluorescence microscopy. Where needed, nuclei were stained 
with 4', 6'-diamidino-2-phenylindole (DAPI), as described (Kilmartin and Adams, 
1984). Cells were fixed with formaldehyde (3.7%) before DAPI staining (see below).  
All microscopy was performed using a Leica DMLB (Leica Pte. Ltd., Singapore) 
microscope fitted with differential interference contrast (Nomarski) optics and 3 kinds 
of fluorescence filtercubes. GFP was observed with a Leica GFP filtercube. 
 
2.3.7 FM4-64 Internalization  
Cells were grown overnight to exponential phase (A600=0.5-0.8, 3-4×107 cells/ml) 
in SD medium. Cells (500µl, 2×107cells) were pelleted at 400×g for 1 min and 
resuspended in 100µl fresh medium. FM4-64 (Molecular Probes, Eugen, OR) was 
added to 40µM from a stock solution of 16mM in dimethyl sulfoxide, followed by 
incubation with shaking at 30 oC. After 15 min, the cells were washed with fresh 
medium and chased for 45-60min. FM4-64 fluorescence was observed with a Leica 
N2.1 filtercube. 
 
2.3.8 4', 6'-Diamidino-2-phenylindole (DAPI) Staining of Nuclei  
DAPI (4', 6'-diamidino-2-phenylindole) is a blue fluorescent nucleic acid dye that 
stains double-stranded DNA (dsDNA). The dye attaches to AT clusters in the DNA 
minor groove. This binding can enhance the fluorescence for 20-fold. The maximum 
                                                                                   - 86 - 
emission of the DAPI/dsDNA complex is of 461nm and was observed with a Leica A 
filtercube. 
Cells were grown to exponential phase (OD595=0.6-0.8). 900 µl of cells were 
inoculated, mixed with 100 µl of 37% formaldehyde and incubated at the growth 
temperature for 10 mins. The cells were spun down in a microfuge and the 
supernatant was discarded. 1ml of PBS containing 1% NP40 was added to the fixed 
cells. Cells were suspended by pipetting and mixed for 30 seconds. Cells were washed 
3 times with PBS and cell pellets were resuspended in 10 µl of DAPI mounting 
medium (50% (v/v) glycerol containing p-phenylenediamine at 1mg/ml and DAPI at 
1µg/ml). 2-3 µl DAPI stained cells were spotted on a slide and a cover slip was placed 
on the drop to let the cell suspension spread uniformly sandwiched between the glass 
slide and the cover slip. To observe DAPI staining, the excitation wavelength is 
360nm and the emission wavelength is 470nm.  
 
2.3.9 Subcellular Fractionation  
Cells were fractionated using differential centrifugation following osmotic lysis, 
as previously described (Paravicini et al., 1992). Cell were grown in rich media (10ml) 
to OD600=1 and then incubated in 1ml 50 mM Tris-HCl, pH 8, 1% 
2-mercaptoethanol for 10 min at 30oC. Cells were then converted to spheroplasts by 
treatment with zymolyase (150µg/ml) in 1ml 1.2M sorbitol, 50mM potassium 
phosphate, pH 7.5, 1 mM magnesium chloride at 30oC for 40 min. spheroplasts were 
washed once in 1.2M sorbitol prior to osmotic lysis in 1.3ml cold 0.2M sorbitol, 
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50mM Tris-HCl, pH 7.5, 1mM EDTA. Unbroken cells were removed by 
centrifugation for 5 min at 500×g (this and all subsequent centrifugation steps were 
performed at 4oC), yielding 1.2ml whole cell extract (WCE). A total of 1.0 ml of 
WCE was subjected to centrifugation at 13,000×g for 10 min to yield a P13 (pellet) 
fraction. The resulting supernatant fraction was subjected to centrifugation at 
100,000×g for 30 min, yielding P100 (pellet) and S100 (supernatant) fractions. The 
P13 and P100 pellets were resuspended in 200µl 2×SDS-PAGE sample buffer (8M 
Urea, 5% SDS, 40mM Tris-HCl, pH6.8, 0.1mM EDTA, 0.4 mg/ml bromophenol blue, 
10% β-mercaptoethanol). Proteins were precipitated from the S100 and 0.2 ml of the 
WCE using 10% TCA, and resuspended in 200µl and 40µl 2×SDS-PAGE sample 
buffer , respectively. 
 
2.3.10 Detergent Resistant Membrane (DRM) Isolation 
To determine Triton X-100 solubility of membranes, an equal volume of ice-cold 
2% Triton X-100 was added to the S1 fraction and the resulting mixture was 
incubated on ice for 30 min. Samples were then subjected to centrifugation at 
100,000×g for 1 h. Pellets (P100) were resuspended in 1% SDS and directly resolved 
by SDS-PAGE, followed by immunoblot analysis with appropriate antisera.  
 
2.3.11 Sucrose Density Gradient Fractionation (Losko et al., 2001) 
400ml culture Grow to OD600 0.3-0.4 (~1×107)  and was harvested by 
centrifugation at 2000g(4000rpm), 10min, 4oC, JLA10-5 rotor (Beckman). The cell 
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pellet was subsequently washed 2 times in 50 ml ice cold water, resuspended in 2ml 
water and transferred equally between 2 Eppendorf tubes. Cells were pelleted at 
300×g, 2min, and 4oC in a benchtop microfuge. Cell pellets were each resuspended in 
75µl STED10 (10% w/w sucrose, 10mM Tris-HCl pH7.6, 1mM EDTA, 1mM DTT, 
protease inhibitors cocktail. 
Cells were lysed in a bead beater (¾ tube with glass beads), 30 sec burst, 2mins on 
ice. This procedure was repeated 4 times. 200µl STED10 (plus protease inhibitors) 
was added to each tube and a hole was pierced in the lid and bottom of each tube. The 
tubes were then placed inside fresh tubes and spun briefly in a microcentrifuge to 
collect the cell lysate. 600µl of STED10 was added and mixed with each sample. The 
lysates were cleared of cell debris by centrifugation at 300×g for 5mins, 4oC 
(2500rpm-Eppendorf centrifuge), the supernatants were carefully removed avoiding 
the cell debris and pooled (~1.2ml) in one tube. 
1ml of supernatant was layered on top of the sucrose gradient. The sucrose 
gradient was prepared as follows: in an SW41Ti centrifuge tube, 3.8ml of STED50 
(53% w/w sucrose), STED35 (35% w/w sucrose) and STED20 (20% w/w sucrose), all 
containing aprotinin, leupeptin, pepstatin A, was layered on top of each other. The 
centrifuge tubes slowly turned to a horizontal position. After 3-5 hours of horizontal 
diffusion, the gradients were again turned into an upright position, loaded with lysate 
and spun for 14-17 hours at 30,000rpm (~100,000×g) in a SW41Ti rotor, 4 oC. After 
centrifugation, 920µl fractions were collected.  
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2.4 Functional Study 
2.4.1 In vivo Assays for Sterol Esterification (Oelkers, P., et al, 2000) 
2.4.1.1 Labeling and Drying 
• Cells (5ml in conical tube) were grown to log-phase (OD595= 0.5- 0.8) at 
30°C. 
• 1μl [3H] oleate (1mCi/ml) was mixed with 25μl tyloxapol/ethanol (1:1) and 
the cells were labeled for 30 mins. 
• One drop (approximately 50μl) of 0.2% azide was added to the culture and 
placed on ice. 
• Cells were precipitated at 1000×g for 5mins and washed with 0.5% tergitol 
(NP40) 5ml two times, deionized H2O 1 time, and transferred to Eppendorf 
tubes 
• Samples were pelleted and supernatant was removed. 
• Microcentrifuge tubes were covered with aluminum foil. Holes were made in 
the ceil with a needle and samples were lyophilized overnight. 
 
2.4.1.2 Cell Lysis and Neutral Lipid Extraction (Parks et al., 1985) 
• The lyophilized cell pellet was weighed and transferred to 15ml conical tubes. 
• 50μl lyticase solution (lyticase 1700 units/ml in 10% glycerol + 0.02% azide) 
was added to these conical tubes. 
• Samples were incubated at 37oC for 15 mins, frozen at -70 oC for 1hr and 
incubated again at 37 oC for 15 mins. 
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• 200μl isopropanol and 0.25μl [14C] cholesterol were added to the samples.  
• Samples were vortexed and then incubated at RT for 30 mins and vortexed 
again. 
• 5ml hexane was added to each sample. 
• Samples were vortexed at full speed for 2mins. 
• 5ml KCl: MeOH (2M KCl: MeOH 4:1) was added to each sample. 
• Samples were vortexed at full speed for 2mins. 
• Samples were centrifuged at 3,000g for 5mins. 
• Top organic phase was transferred into glass tube. 
• Hexane was evaporated under nitrogen. Lipids were resuspended in 100 μl 
CHCl3: MeOH (2:1). 
• Samples were spotted on DC-Plastikfolien Kieselgel 60 TLC plates (E-Merck, 
Germany). The plates were developed in hexane: diethyl ether: acetic acid 
(70:30:1) and stained with iodine vapor. Each lane was excised according to 
lipid standards. 
• The cut lanes were incubated with 5 ml of Betamax and incorporation of [3H] 
oleate was measured in a liquid scintillation counter. 
Note: This protocol was optimized for 2-5 mg (dry weight) pellets. The lyticase 
does not hydrolyze lipid esters while zymolyase has lipid hydrolytic activity. 
0.25μl [14C] cholesterol was added as an internal standard. (Oelkers, P., et al, 
2000) 
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2.4.2 In vivo Assays for Sterol Esterification Under Acute Glucose Starvation 
Condition 
Cells were grown in YPD to mid-log phase, harvested, washed three times with 
water and resuspended in YP. Cells were then cultured in YP for up to 2 hours. At 
various time points after changing medium, cells were pulse labeled with 3H-oleic 
acid for 30 minutes. Total lipids were prepared and analyzed as described above. 
Incorporation of label into ergosterol ester was determined by liquid scintillation 
counting and normalized to a [14C] cholesterol internal standard and the dry weight of 
the cells. The data is expressed as means of triplicate assays for at least five 
independent experiments with the corresponding standard deviations.  
 
2.4.3 Acetate Incorporation Assay   
The incorporation of [1-14C] acetate into non-saponifiable lipids was assessed as a 
measurement of sterol synthesis.  
Approximately 2 OD600 units of cells were incubated with 20µCi [1-14C] acetate 
in 2ml defined media at 30°C for 2 hours and subjected to saponification reaction, 
hexane extraction and TLC chromatography. The incorporation of redioactivity into 
total sterols was assessed by liquid scintillation counting.  To normalize the estimate 
of sterol biosynthesis to incorporation of acetate into the fatty acid pool, the aqueous 
lysate remaining after hexane extraction of the soponified preparation was acidified 
with concentrated HCl and re-extracted with hexane (Dimster-Denk et al., 1994). The 
extracted lipids were separated by TLC and measured with scintillation counter. 
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 2.4.4 In vitro (Microsomal) Assay of Sterol Esterification (Yang, R. H., et al, 1996) 
2.4.4.1. Isolation of Microsomes (Zinser E. 1995) 
• 20ml cells were grown overnight and reinoculated into 1 liter YPD to 
OD600=0.2.  
• After growing for 4 hours, the cells were washed three times with distilled 
H2O and resuspended in 1 liter YP. The cells were incubated at 30°C for 
30mins. 
• Cells were harvested. The pellets were washed 2 times with distilled H2O, 
suspended and incubated in 1ml 0.1M Tris-SO4 (with 10mM DTT)/0.5g wet 
cell weight at room temperature for 10min.  
• Cells were precipitated, washed once with 1.2M sorbitol, and resuspended in 
1ml 1.2M sorbitol (with 20mM K2PO4 and 0.5mg/ml lyticase, pH 7.2)/0.15g 
wet cell weight. Samples were incubated at 30oC for 90mins. 
• Spheroplasts were precipitated, washed twice with 1.2 M sorbitol, resuspended 
in breakage buffer and disrupted with 20 strokes in a Dounce homogenizer 
using a tight fitting pestle at 4oC.  
• Homogenates were centrifuged at 20,000g for 30 min. The pellets were 
discarded.  
• Supernatants were precipitated at 100,000g for 45 min. The final pellets 
containing microsomes were resuspended in 10mM Tris-HCl pH 7.4. Protein 
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concentrations were determined by the Bradford assay, using bovine serum 
albumin as standard.  
 
2.4.4.2 Reaction System 
Table 1 Reaction system for sterol in vitro esterification assay  
 Stock concentration Volume added Final 
concentration 
microsomes   80μg  
cholesterol 0.4μg/μl 50μl  
BSA 150µM 20µl 15µM 
oleoyl-CoA 10mM 2µl 50 µM 
1-[14C] oleoyl-CoA 50 µCi/ml 5µl 1.25 nCi/µl 
ACAT assay buffer:  
  
0.1M K3PO4     
1 mM glutathione 
 




2.4.4.3 Measure of Sterol Esterification Activity 
• Reagents without oleoyl-CoA were mixed as shown in table 1. 
• Mixture was incubated at 37oC for 10 min. 
• At 15-30 second intervals, 7µl [14C] oleoyl-CoA and cold oleoyl-CoA mix 
was added into each tube. 
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• After 10 min, again at 15-30 seconds intervals, 4 ml of choloroform: methanol 
(2:1) was added into each tube and vortexed for 5 seconds. 
• 15µl of cholesterol oleate (1mg/ml) were added to each sample. 1µl [3H] 
cholesterol and 15µg triolein were added as internal standards. 
• Samples were vortexed for 15 seconds.  
• 800 μl water were added to each sample and vortexed for 30 seconds. 
• Phases were separated by centrifuging at 13,000 rpm for 5 min. 
• The chloroform layer (at the bottom) was transferred to a glass tube. 
• Chloroform was evaporated by a stream of nitrogen gas. Lipids at the bottom 
of the glass tubes were dissolved in 100μl of CHCl3: MeOH (2:1). 
• Samples were spotted onto TLC plates. The plates were developed in hexane: 
diethyl ether: acetic acid (70:30:1) and stained with iodine vapor. Each lane 
was cut according to lipid standards. 
• The cut lanes were put into 5 ml of Betamax scintillation cocktail and 
incorporation of [14C] oleoyl-CoA was measured by a lipuid scintillation 
counter. 
Note: Enzyme activity was determined by the incorporation of [14C] oleoyl-CoA 
into cholesterol. Each standard assay was performed in triplicate. In control assays, 
all the components were the same except that microsomes were omitted.  
 
2.4.5 GST Pull-down Assay: 
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• Yeast cells were grown in 10ml minimal medium (SD and supplementary 
amino acids) overnight at 30 °C and reinoculated to an OD600=0.2 in 100ml 
SD. 
• Cells were harvested at OD600=1.0, washed three times with H2O and 
resuspended in 2ml binding buffer (50mM Tris-HCl, pH 7.5, 150 mM NaCl, 
0.1 mM EDTA, 1mM DTT, protease inhibitors and 1% Triton X-100). 
• The suspension was split into 2 microcentrifuge tubes. 400μl glass beads were 
added to each tube. 
• The cells were broken with a beads beater by 30 sec bursts, 2mins intervals on 
ice, for 4 times.  
• A hole was pierced in the lid and bottom of each tube. The tubes were then 
placed inside fresh tubes and spun briefly in a microcentrifuge to collect all 
cell lysate.  
• The cell lysate was precipitated at 500×g and the supernatant collected in a 
new clean microcentrifuge tube.  
• 50μl 50% glutathione (GSH) sepharose slurry was centrifuged, equilibrated 
with binding buffer and added to the cell lysate. The tube was incubated on a 
roller at 4°C for 1 hour. 
• Samples were centrifuged and washed three times with washing buffer (50mM 
Tris hydrochloride, pH 7.5, 150 mM NaCl, 0.1 mM EDTA, 1mM DTT, 
protease inhibitors and 0.2% Triton X-100) at 4°C for 30mins.  
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• The GSH beads were precipitated by centrifugation. 50μl of 2×protein loading 
buffer (8M Urea, 5% SDS, 40mM Tris-HCl, pH6.8, 0.1mM EDTA, 0.4mg/ml 
bromophenol blue and 10% 2-mercaptoethanol) was added to the tube to 
dissolve proteins from the GSH beads.  
• Samples were centrifuged at 13,000 rpm for 5mins. The supernatant was 
collected for Western blot analysis.  
 
2.4.6 β-galactosidase Assay with ONPG as Substrate in Liquid Culture 
pMCZ-Y was a gift from K. Mori (HSP Research Institute, Shimogyoku, Japan) 
• Cells were grown overnight at 30°C and reinoculated to 5ml YPD for 3–5 
hours to OD600= 0.5–0.8 at day 2. The exact value of OD600 was recorded for 
later calculation. 
• Cultures were split into 3 1.5ml tubes and precipitated at 13,000 rpm for 
30sec. 
• Pellets were washed and resuspended in 1.5 ml of Z buffer (60mM Na2HPO4, 
40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 50mM β-mercaptoethanol, 
pH7.0). 
• Cells were precipitated and resuspend in 300µl Z buffer. 
• 100µl of cell suspension were transferred into a fresh microcentrifuge tube. 
• The tubes were dipped into liquid nitrogen until the cells were frozen. Cells 
were thawed in a 37°C water bath for 0.5–1 min. 
• A blank tube with 100µl of Z buffer was set up as the negative control. 
                                                                                   - 97 - 
• 0.7 ml of Z buffer was added to reaction and blank tubes. 
• 160µl 4 mg/ml ONPG in Z buffer was added to reaction and blank tubes. The 
tubes were incubated at 30°C until the solutions developed a yellow color. 
• 0.4 ml 1M Na2CO3 was added to the reaction and blank tubes. The elapsed 
time since the addition of ONPG was recorded in minutes. 
• Cell debris were precipitated at 13,000 rpm for 10 min. The OD of the 
supernatant was measured at 420nm in a spectrophotometer. 
• β-galactosidase units were calculated using the following formula:  
β-galactosidase units = 1000 x OD420/(t x V x OD600) 
Where: t = elapsed time (in min) of incubation 
V = 0.1 ml ×concentration factor 
1 unit of β-galactosidase is defined as the amount which hydrolyzes 1mol of 
ONPG to o-nitrophenol and D-galactose per min (Miller, 1972) 
Note:  
• The amount of recovered cells may differ after the washing Step 3. It can be 
resolved by reading the OD600 again after resuspending cells.  
• The cellular debris, if disturbed, will strongly interfere with the accuracy of 
this test. The OD should be between 0.02–1.0 
 
2.4.7 Isolation of Intact Vacuoles from Yeast (Hass, 1995) 
• Cells were grown in 20ml YPD at 30 oC for overnight and reinoculated to 
1000ml YPD at the second day. Cells were harvested at an OD600=0.8 
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• Cells were sedimented in a Beckman JA-14 rotor for 5 min at 5,000rpm 
• The pellet was resuspended in 50ml freshly prepared DTT/PIPES buffer 
(100mM PIPES/KOH, pH9.4, 10mM DTT). 
• The resuspended cells were incubated in a water bath at 30oC for 10mins 
followed by 5,000rpm centrifugation for 5mins with the same rotor.  
• The cell pellet was resuspended in 15ml spheroplasting buffer (0.6M 
D-sorbitol, 0.16×YPD, 50mM potassium phosphate, pH7.5, 0.4mg 45,000 
U/mg oxalyticase) and transferred into 30ml Corex glass tubes. 
• The suspension was incubated at 30oC for 25min and periodically checked 
under the microscope until most of the S. cerevisiae cells were completely 
round.  
• The spheroplasts were centrifuged at 2,500rpm 4oC for 1min, and then 
supernatant was spun at 3,500rpm for 1min. 
• The cell pellet was carefully collected and put on ice. 2.5ml 15% Ficoll 
solution (15% Ficoll-400, 10mM PIPES/KOH, pH6.8, 200mM sorbitol) was 
added and the spheroplasts gently suspended without vortexing.  
• 2.5ml freshly prepared dextran solution (1mg dextran in 2.5ml 15% Ficoll 
solution) was added to the spheroplasts suspension and gently mixed.  
• The mixture was put on ice for 2min followed by incubating the sample in a 
30oC water bath for 1min to disrupt the cell membranes. Samples were put on 
ice and cell lysis was examined by phase contrast microscopy.  
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• Cell lysate was transferred into SW41Ti centrifuge tubes. 3ml of 8% Ficoll 
solution, 3.5ml 4% Ficoll solution, and then 3ml 0% Ficoll solution (10mM 
PIPES/KOH, pH6.8, 200mM sorbitol) were carefully layered to create a step 
density gradient. The gradient was centrifuged at 30,000rpm and 4oC for 
90min (100,000×g) in a SW41Ti rotor.  
• The lipid layer on top of the gradient was removed. 400-600µl milky vacuole 
fraction from the 4%/0% Ficoll interface was carefully collected.  
The vacuole preparation from this protocol is 45- to 50-fold enriched for vacuolar 
proteins with respect to the total proteins applied to the gradient. Cytosolic, endosome 
and endoplasmic reticulum markers are found only in trace amounts. 
 
2.4.8 Isolation of Vacuolar Lipids.  
Vacuoles were isolated as described under 2.4.7. Lipids were extracted and 
separated by thin layer chromatography (TLC) as described under 2.4.1. Free 
ergosterol was detected and quantified by direct densitometry scanning at 275nm 
using a CAMAG TLC Scanner 3 (Sorger et al., 2004). Total vacuolar protein was 
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Chapter 3 Localization and Transport of Ncr1p 
3.1 Introduction 
In mammalian cells, the NPC1 protein has been shown to reside in an endosomal 
compartment that is involved in the retrograde transport of multiple lysosomal cargos 
(Neufeld et al., 1999). It was later demonstrated that NPC1 predominantly localizes to 
late endosomes, but transiently associates with lysosomes and the trans-Golgi network 
(TGN) (Higgins et al., 1999; Zhang et al., 2000). Recent elegant microscopic studies 
revealed that newly synthesized NPC1 moves from the endoplasmic reticulum 
through the Golgi apparatus before reaching late endosomes (Zhang et al., 2001). In 
addition, the NPC1-containing late endosomes undergo dynamic tubulovesicular 
movements along microtubules, and this movement may be associated with transfer of 
cargo between subcellular organelles (Zhang et al., 2001; Ko et al., 2001). Despite 
intensive investigation, the precise function of NPC1 in intracellular lipid transport 
and in the pathogenesis of NPC remains to be elucidated. In particular, it is not clear 
whether NPC1 acts directly on lipid transport or on endocytic trafficking events, since 
both are affected when NPC1 function is lost (Neufeld et al., 1999; Kobayashi et al., 
1999). Ko et al. (2001) provided evidence that NPC1 promotes the creation and/or 
movement of a subset of late endosomes; other groups maintain that the effect of 
NPC1 mutation on endosomal movement is indirect and caused by cholesterol 
accumulation (Zhang et al., 2001; Lebrand et al., 2002). On the other hand, if NPC1 
does function as a cross-membrane lipid transporter, it is not clear which lipid species, 
e.g. sterols, sphingolipids or fatty acids, serve as the cargo under physiological 
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conditions (Davies, 2000; Malathi et al., 2004). 
The homologous open reading frame (ORF) to human NPC1 (42% identity, 75% 
similarity at protein level) was identified in yeast and named NCR1 (for NPC1 related 
gene 1) (Malathi, 2004; Sturley, 2000). The predicted structural features of Ncr1p are 
also strikingly homologous to those of NPC1. Ncr1p possesses multiple membrane 
spanning domains, an NPC domain with a leucine zipper motif and, more importantly, 
a putative sterol-sensing domain. It has been shown recently that deletion of NCR1 
had no effect on sterol synthesis, esterification and uptake and that a mutant form of 
NCR1 gave rise to defects in cellular sphingolipid homeostasis (Malathi et al., 2004). 
However, as is the case for its mammalian counterpart, the biochemical function of 
the native Ncr1p protein remains to be defined. In this study, we show that Ncr1p 
localizes to the limiting membrane of the yeast vacuole but does not have an essential 
role in endocytic membrane transport. 
 
3.2 Results  
3.2.1 Purification of Ncr1 189 aa peptide with Talon® beads 
In order to characterize and understand Ncr1p function, antibodies against Ncr1p 
were produced. As the antigen, an Ncr1p peptide from amino acid residues 807-995 
fused with a 6-histidine tag was expressed in E. coli M15, followed by IPTG 
induction. In order to check the solubility of the recombinant protein, the M15 cells 
were lysed by sonication. The parameters used for sonification is pulse 30”, pause 30”, 
and repeated for 10 mins. The total lysate was centrifuged to separate the supernatant 
and pellet. Preliminary experiment showed that the expected peptide was mainly in 
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the pellet. The pellet was dissolved in 8M urea and was purified using Talon® beads. 
The purified peptides in the eluted fractions were analyzed by SDS-PAGE followed 
by Coomassie blue staining. Figure 3.1A. shows the purified Ncr1p peptides in 
fractions 2-4. The peptides were mainly present in the pellet, which indicates the 
189aa Ncr1p peptideswas largely insoluble in the E. coli expression system. 
 
3.2.2 Purification of the Ncr1p 189aa Peptide by Electroelution. 
In order to remove the nonspecific bands after affinity purification, the further 
purification was done by electroelution. Initially an HPLC method was tried, but the 
purification on Mono Q HR 5/5, an anion exchange column, was not successful.  
Therefore, after purification by Talon® beads, purer bands were tried to obtain by 
electroelution. Figure 3.1B shows the purified bands of Ncr1p peptides after 
electroelution from SDS-PAGE. Since the molecular weight of the expected band is 
about 27KD, the dialysis membrane with a molecular weight cut off (MWCO) of 
12K-15kDa was used. However, the amount of peptide recovered was much less than 
that of the original sample. If the protein is globular in shape and its molecular weight 
is larger than 12-15KDa, the protein cannot pass across the dialysis membrane. On the 
other hand, if the protein is linear in shape, even high molecular weight, it still can 
pass through the dialysis membrane. Since the buffer contained 0.5% SDS, proteins in 
this buffer will be linear. Considering this, another dialysis membrane with a MWCO 
of 3.5kDa was tried. There, the amount of recovered peptide was much higher.  
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Figure3.1 Purification of Ncr1 peptides and generation of polyclonal antisera against 
Ncr1p. A) Purification of a Ncr1p fragment by Talon beads. B) Purification of peptides 
from Talon beads by electroelution. C) A peptide containing residues 807–995 of Ncr1p 
was used to immunize rabbits and the serum was used directly in an immunoblot analysis 
of protein extracts from WT (BY4741), ncr1Δ (Y02822) and ncr1Δ with a multicopy 
plasmid containing NCR1 under its native promoter. 
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3.2.3 Ncr1p Antibody Preparation and Detection of Ncr1p in S. cerevisiae Cells 
The purified peptides from E.coli were used to immunize and boost two rabbits. 
The rabbits were bled and the blood was centrifuged to obtain the serum. This 
anti-serum was diluted by 1:1000 and used directly to detect Ncr1p. The 
immuno-blotting results are as shown in Figure 3.1C. Total lysates were used to run 
the SDS-PAGE. As shown in the figure, a ~130 kDa protein band was present in 
protein extracts from wild-type (BY4741), but not from ncr1Δ (Y02822) yeast cells. 
In addition, when Ncr1p was moderately over-expressed in Y02822, the intensity of 
the ~130 kDa band increased, further confirming that this band is indeed Ncr1p. 
 
3.2.4 Ncr1p is Predominantly Located in the P13 Membrane Fraction 
As the first step towards understanding the molecular function of Ncr1p, we 
decided to examine its subcellular localization.  
 
To gain insights into the intracellular localization of Ncr1p, differential 
centrifugation was used to separate various organelles. Cell extracts prepared from a 
wild-type strain (BY4741) were centrifuged at 13,000×g for 10 min, resulting in a 
medium-speed pellet (P13) and supernatant (S13) fractions. The S13 was further 
centrifuged for 1 hour at 100,000×g to obtain a high-speed pellet (P100) and 
supernatant (S100) fractions. The whole cell extract, P13, P100 and S100 fractions 
were probed with various antibodies against Ncr1p and specific resident proteins of 
subcellular compartments. As shown in Figure 3.2A, Ncr1p was predominantly found 
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Figure 3.2 A












Figure3.2 Ncr1p and NCR1-GFP localize to the limiting membrane of yeast vacuoles. A) 
Differential centrifugation analysis of yeast proteins. WT (BY4741) and strains expressing 
NCR1-GFP were spheroplasted and subjected to differential centrifugation as described in 
Materials and Methods. The low-speed pellet (P13), high-speed pellet (P100) and soluble 
(S100) fractions were analyzed by immunoblotting using specific antisera. CEN, low copy 
plasmid; 2μ, multicopy plasmid. B) Wild-type (BY4741) and strains expressing Ncr1p-GFP 
were lysed in STED buffer using glass beads and a 300×g supernatant (S1) was loaded on 
the top of a sucrose gradient (10-53%) and centrifuged at 100,000×g for 15 h. Fractions 
were collected from the top, separated by SDS-PAGE and immunoblotted with specific 
antisera. Markers: plasma membrane (Gas1p), ER (Dpm1p), PVC (Pep12p) and vacuolar 
membrane (ALP and Vph1p). C) A GFP-tagged, full length Ncr1p on a CEN4 plasmid was 
expressed from its native promoter in log-phase ncr1Δ (Y02822) cells. Scale bar, 5 µm. 
DIC: differential interference contrast. 
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in the P13 fraction, which contains membranes derived from the vacuole, plasma 
membrane, endoplasmic reticulum, mitochondria and nuclei. In addition, endosomal 
membrane is present in both P13 and P100. This is somewhat surprising because 
mammalian NPC1 was shown to reside mainly in endosomes. Instead, Ncr1p in yeast 
exists in a more dense membrane than the endosome. 
 
3.2.5 Ncr1p Localizes to the Limiting Membrane of Yeast Vacuole  
P13 membrane is a mixture. From the above result, the exact location of Ncr1p 
cannot be derived. To better define the subcellular location of Ncr1p, cell extracts 
were subjected to continuous sucrose density gradient analysis. Thirteen fractions 
were collected from top to bottom (1-13) and probed for the presence of Ncr1p, 
Pep12p (endosomal), alkaline phosphatase (ALP) (vacuolar membrane), Vph1p 
(vacuolar membrane), Dpm1p (endoplasmic reticulum) and Gas1p (plasma membrane) 
by immuno-blotting. For Ncr1p, a single peak that coincided with the peaks of ALP 
and Vph1p was observed, indicating a vacuolar localization of Ncr1p (Figure 3.2 B).  
 
3.2.6 Localization of Ncr1p-GFP 
To further confirm the subcellular localization of Ncr1p, an NCR1-green 
fluorescent protein (GFP) fusion was made and observed in a fluorescence 
microscope. The microscope image indicated that Ncr1p-GFP is almost exclusively 
localized to the vacuole membrane (Figure 3.2C). Additionally, Ncr1p-GFP showed 
identical density properties to the native protein, suggesting that its localization can 
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accurately represent that of Ncr1p (Figure 3.2A& B). 
The study on localization of Ncr1p-GFP and its native protein provided very 
strong evidence that Ncr1p localizes to the limiting membrane of the vacuoles in S. 
cerevisiae under laboratory growth conditions. 
 
3.2.7 Ncr1p is not Associated with Detergent-resistant Membranes (DRMs) 
Studies on mammalian NPC1 suggested that NPC1 is a raft-associated protein 
(Garver, 2000). Rafts are mainly present in PM and Golgi membranes. The vacuolar 
nature of Ncr1p does not suggest the same property for Ncr1p, as raft-like 
microdomains on the limiting membrane of the vacuole have not been observed yet in 
yeast. Rafts and associated proteins are insoluble in cold, nonionic detergents, such as 
Triton X-100, in yeast (Bagnat, 2000). To test whether Ncr1p associates with a Triton 
X-100 insoluble fraction, cell lysates were incubated with Triton X-100 on ice and 
then centrifuged at 100,000×g, generating detergent-soluble and detergent-insoluble 
fractions (Figure 3.3). Ncr1p was only found in the S100 fraction, indicating efficient 
Triton X-100 solubilization, whereas Gas1p, a known raft-associated protein in the 
plasma membrane, could not be fully solubilized by Triton X-100 and remained 
largely in the pellet.  
 
3.2.8 Vacuolar Localization of Ncr1p is Impaired in Mutants Affecting Early but 
not Late Steps of the Secretory Pathway  
Many vacuolar proteins pass through the early stages of the secretory pathway 












Figure 3.3 Ncr1p is not a DRM-associated protein. Wild-type yeast (BY4741) cells 
were grown to mid-log phase, spheroplasted and lysed. An S1 fraction was obtained 
after centrifugation at 300×g for 5min. An equal volume of ice-cold 2% Triton X-100 
was added to the S1 fraction and the resulting mixture was incubated on ice for 30min. 
Samples were then subjected to centrifugation at 100,000×g for 1 h. Pellets (P100) were 
resuspended in 1% SDS and directly resolved by SDS-PAGE, followed by 
immunoblotting using corresponding antisera. WCE: whole cell extract, which is the S1 
fraction. 
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and a prevacuole compartment (PVC) before arriving at the vacuole. To test whether 
the secretory pathway is involved in the trafficking of Ncr1p, localization of Ncr1p in 
temperature-sensitive sec mutants, i.e. sec18 (RH2043), sec7 (AFY72) and sec1 
(RH1372), was determined by fluorescence microscopy. For this, a multicopy plasmid 
containing the fusion gene NCR1-GFP was transformed into the sec mutant strains. 
Cells were grown to early log phase at permissive temperatures and then shifted to the 
restrictive temperatures followed by incubation for 90 minutes. As shown in Figure 
3.4, the GFP fluorescence in sec18 and sec7 cells is present in nonvacuolar 
compartments. Interestingly, the sec18 strain showed fluorescence in a ring around 
the nucleus, indicating accumulation of Ncr1p-GFP in the ER when sec18 function is 
lost (Figure 3.4A). The nonvacuolar compartments in sec7 mutants probably reflect 
the Golgi, since protein secretion has been shown to be blocked at the Golgi, in sec7 
mutants (Franzusoff, 1989) (Figure 3.4B). In contrast, wild-type and sec1 mutant 
cells grown at either permissive or restrictive temperatures exhibited almost 
exclusively Ncr1-GFP fluorescence on the vacuole membrane (Figure 3.4B), 
suggesting that late secretory vesicles and the plasma membrane are not involved in 
Ncr1p transport under normal growth conditions. 
 
3.2.9 Vacuolar Localization of Ncr1p is Impaired by the Defect in the Vacuolar 
Protein Sorting (VPS) Pathway and Vacuole Morphology, but not in Endocytosis 
or ALP Pathway  
In yeast, two pathways have been well established for proteins to be delivered 












Figure 3.4 Transport of Ncr1p is impaired in mutants affecting early but not late steps of 
the secretory pathway. Localization of Ncr1–GFP was determined in temperature sensitive 
(ts) mutants of the secretory pathway (A, sec18; B, sec7 and sec1) at both permissive and 
non-permissive temperatures. In the case of sec18 mutants, DAPI was used to stain the 
nuclear DNA. Scale bar, 5 µm. 
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from the Golgi to the vacuole. The first pathway utilizes PVC, which is taken by the 
vacuolar H+ATPase (Vph1p) and other proteins (VPS pathway). The second pathway 
is a cargo-selective direct transport system mediated by the AP-3 adaptor complex 
(Cowles, 1997) and is taken by ALP and other several preteins (ALP pathway). In 
addition, certain plasma membrane proteins are delivered to the cell surface first and 
then internalized and delivered to the vacuole for degradation via early and late 
endosomes. The fact that normal Sec1p function is not required for the vacuolar 
localization of Ncr1p rules out the possibility that the PM is an essential intermediate 
for Ncr1p to reach the vacuole. Therefore, we sought to determine whether Ncr1p 
transits through the PVC (VPS pathway) or AP-3 vesicles (ALP pathway).  
VPS4 encodes an AAA-ATPase that is required for biosynthetic or endocytosed 
materials to exit the PVC (Babst, 1997). In vps4 mutants, an enlarged PVC 
compartment, the class E compartment (Raymond, 1992), can be found containing 
newly synthesized vacuolar, endocytosed plasma membrane, and recycling Golgi 
membrane proteins. Apm3p is an essential component of the AP-3 adaptor complex. 
Transport of vacuolar membrane proteins by the ALP pathway is blocked in apm3Δ 
mutant.  
To determine which pathway is critical for the Golgi-vacuole transport of Ncr1p, 
differential centrifugation experiments were performed. In wild-type cells, Ncr1p was 
found in the P13 fraction (Figure 3.2B). In contrast, a significant portion of Ncr1p 
and Vph1p was found in the P100 fraction in vps4Δ cells (Y05588) (Figure 3.5A). 
When similar experiments were performed in an apm3Δ mutant strain (Y07174), 




















Figure 3.5 Vacuolar localization of Ncr1p is impaired in mutants affecting vacuole protein 
sorting and vacuole morphology, but not in mutants affecting endocytosis or the ALP 
pathway. A) Analysis of Ncr1p in various mutant strains by differential centrifugation. 
Yeast cells were grown to mid-log phase, spheroplasted, subjected to differential 
centrifugation and immunoblotted by antisera against Ncr1p. B) Ncr1-GFP on a single 
copy plasmid in various deletion strains. Cells were grown to mid-log phase, collected and 
visualized. Scale bar, 5 µm. 
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Ncr1p was detected only in the P13 fraction. This size/density shift of 
Ncr1p-containing compartments in vps4Δ strongly suggests that nascent Ncr1p, like 
Vph1p, transits through the PVC via the VPS pathway from the Golgi to the vacuole, 
and does not use the ALP pathway. To further confirm our findings from differential 
centrifugation analysis, we transformed the vps4Δ strain and the wild-type (WT) 
strain (BY4741) with a low copy number plasmid expressing NCR1GFP under the 
control of its native NCR1 promoter (YCp111-Ncr1–GFP). In the WT strain and 
apm3Δ mutant, Ncr1p–GFP was seen almost exclusively on the vacuole membrane 
(Figures 3.2C and 3.5B), whereas in vps4Δ, it was detected in a typical class E 
compartment.  
Similar experiments were performed using fluorescence microscopy and 
differential centrifugation methods in a variety of deletion mutants affecting the VPS 
pathway (pep12Δ, vps45Δ, vps1Δ and vps27Δ) and vacuole morphology (vam3Δ). As 
shown in Figure 3.5, the localization of Ncr1p was affected in all of these mutants, 
further confirming the vacuolar nature of Ncr1p and the critical role of the VPS 
pathway in the transport of Ncr1p from the Golgi to the vacuole (Bryant, 1998).  
To test whether a portion of Ncr1p cycles between the plasma membrane and the 
vacuole at steady state, microscopy and differential centrifugation experiments as 
described above were performed in end4Δ mutant in which the uptake step of 
endocytosis is blocked (Wesp, 1997). No obvious accumulation of Ncr1p on the 
plasma membrane was observed (Figure 3.5B). Therefore, Ncr1p does not appear on 
the PM and enter the vacuole through endosomal recycling at steady state.  
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 3.2.10 Deletion of 11 Amino Acids at the Carboxyl Terminus of Ncr1p does not 
Perturb its Localization 
Mutational studies suggested that the C-terminal di-leucine motif is essential for 
the function and lysosomal localization of NPC1 in mammalian cells. Ncr1p is an 
integral membrane protein and its hydrophobicity plot is strikingly similar to that of 
NPC1. Thus, the topology of Ncr1p could be very similar to that of NPC1, with 13 
transmembrane domains and a cytoplasmic carboxyl terminus (Davies, 2000). We 
deleted the 11 C-terminal hydrophilic amino acid residues (SYRDDSIEAED) of 
Ncr1p and performed differential centrifugation and density gradient analysis. The 
truncated protein (Ncr1pΔC11) still appeared in the P13 fraction (Figure 3.6A) and 
peaked at the same fractions as ALP and Vph1p (Figure 3.6B), indicating that the 11 
C-terminal amino acids are not essential for its proper sorting. 
 
3.2.11 Loss of Ncr1p does not Affect ALP Transport to the Vacuole 
Previous studies indicated that lysosomal retroendocytosis, sorting of lysosomal 
enzyme receptor and endosomal movement was impaired in mammalian NPC cells 
(Neufeld, 1999; Ko, 2001; Kobayashi, 1999). More recent studies suggested that 
accumulation of cholesterol had a direct inhibitory effect on endosomal 
tubulovesicular movement (Zhang, 2001; Lebrand, 2002). It was not clear, however, 
whether NPC1 had a direct role in endosomal trafficking events as malfunction of 
NPC1 is often associated with accumulation of sterol in mammalian cells. Since 
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Figure 3.6 Deletion of the C-terminal 11 amino acids of Ncr1p has no effect on its 
vacuolar localization. The plasmid pNCR1ΔC11, which expresses a truncated form of 
NCR1 under its native promoter, was made and introduced into an ncr1Δ strain (Y02822). 
Cells containing pNCR1ΔC11 were grown to mid-log phase, lysed and then analyzed by 
differential centrifugation (A) or density gradient fractionations (B) as described in 
Figure3.2. 
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techniques to examine biosynthetic traffic to the yeast vacuole are well established, 
yeast offers a good system to determine whether Ncr1p has any role in endocytic 
trafficking when there are no obvious changes in cellular sterol homeostasis. 
Although we have clearly shown that Ncr1p is localized on the vacuole at steady state, 
which is the end-point of the endocytic pathway, we could not rule out the possibility 
that Ncr1p was also functionally active when it transits the Golgi and endosomes. 
We examined whether loss of Ncr1p affected the functional integrity of a 
transport pathway from Golgi to the vacuole: the AP3 pathway. This pathway requires 
the clathrin adaptor protein complex AP-3 and is taken by proteins like ALP and 
Vam3p (Yeo et al., 2003). A plasmid expressing ALP-GFP was introduced into WT 
(BY4741) and ncr1Δ (Y02822) strains. In both cases, ALP-GFP was found 
exclusively on the vacuolar membrane (Figure 3.7). 
 
3.3 Discussion 
The mammalian NPC1 gene was first isolated in 1997 (Carstea et al., 1997). 
Since then, significant progress has been made towards understanding the subcellular 
localization and movement, the structure-function relationship and its role in cellular 
cholesterol and sphingolipid trafficking. Despite these advances, the exact molecular 
function of this important protein remains to be elucidated. To help understand the 
basic biochemical function of NPC1, we decided to study its ortholog (Ncr1p) in the 
model eukaryotic organism, S. cerevisiae. Despite millions of years of evolution, 
NPC1 and Ncr1p share striking sequence and structural similarity: their amino acid 
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ALP-GFP
DIC GFP
Figure 3.7 Loss of Ncr1p has no effect on endocytic membrane trafficking. Sorting 
of alkaline phosphatase (ALP) is not affected by loss of Ncr1p. An ALP-GFP 
fusion protein was expressed in WT (BY4741) or ncr1Δ (Y02822) cells and 
observed under a fluorescence microscope, as described chapter 2. Scale bar, 5 µm. 
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sequences are more than 35% identical and they share almost identical hydrophobicity 
plots. Therefore, it is likely that Ncr1p and NPC1 possess very similar if not identical 
basic molecular functions. 
As an initial step in analyzing Ncr1p, we carefully characterized its subcellular 
localization and trafficking in yeast. By differential centrifugation and density 
gradient analysis, Ncr1p largely co-fractionated with Vph1p and ALP, two vacuole 
membrane-resident proteins. In addition, Ncr1p-GFP localized almost exclusively to 
the limiting membrane of the vacuole. Therefore, we conclude that Ncr1p is a protein 
of the vacuole membrane under laboratory growth conditions. In agreement with its 
vacuolar nature, we also observed that Ncr1p is not a DRM-associated protein. DRMs 
in the vacuolar membrane have not yet been reported (Bagnat, 2000). Lastly, by 
examining Ncr1p localization in a variety of mutant strains, we found that nascent 
Ncr1p transits through early stages of the secretory pathway and the PVC before 
reaching the vacuole. Ncr1p is not delivered to the PM either during its biosynthetic 
trafficking or through the vacuole to the PM recycling, as its localization was not 
affected in the end4Δ mutant. However, we were not able to determine whether a 
small portion of Ncr1p cycles between the vacuole, endosomes and the Golgi. On the 
other hand, since nascent Ncr1p transits through Golgi and endosomes, it is possible 
that Ncr1p might be functionally active in the Golgi and endosomes on its way to the 
vacuole.  
Previous studies have suggested that the vacuole is a default destination for 
membrane proteins in yeast (Nothwehr, 1994). Identification of sorting signals on 
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ALP demonstrated that active sorting is required for membrane proteins to take the 
ALP pathway to the vacuole. However, a sorting signal has yet to be identified for 
vacuole membrane proteins taking the VPS pathway. The mammalian NPC1 has a 
di-leucine motif at its carboxyl-terminus, which was shown to be essential for its 
proper localization and function. The yeast Ncr1p does not have a di-leucine motif at 
its carboxyl-terminus and, consistent with the view that membrane proteins taking the 
VPS pathway to the vacuole do not require a signal, the expression and localization of 
Ncr1p was not affected when its 11 C-terminual amino acids were deleted. Although 
we cannot rule out the possibility that vacuole targeting signals exist in other parts of 
Ncr1p, it is more likely that the vacuole is the default destination for Ncr1p. 
Accumulation of lipids in a lysosomal or late endosomal compartment is the 
most prominent defect in mammalian cells lacking normal NPC1 function. Other 
cellular defects, such as impaired lysosomal retroendocytosis, missorting of a 
multifunctional receptor (MPR) and loss of normal endosomal movement have also 
been detected in NPC1 mutant cells (Neufeld et al., 1999; Zhang et al., 2001; Ko et.al, 
2001; Kobayashi, 1999). Although most experimental evidence points to a direct role 
of NPC1 in subcellular lipid transport, one cannot exclude the possibility that the 
primary function of NPC1 is not related to lipid transport at all. For instance, NPC1 
could have a direct role in membrane trafficking events, such as vesicle motility, 
vesicle budding or membrane fission. As a consequence of malfunctions in these 
vesicular trafficking events in NPC1 mutant cells, lipids may accumulate in 
endosomes/lysosomes.  
                                                                                   - 120 - 
However, a series of experiments indicate that ncr1Δ cells do not show 
significant defect in endocytic membrane transport, fluid-phase endocytosis, 
receptor-mediated endocytosis and multi-vesicular body (MVB) sorting (Zhang et al., 
2004).  
We examined whether loss of Ncr1p affected the functional integrity of another 
transport pathway from Golgi to vacuole: the ALP pathway, which requires the 
clathrin adaptor protein complex AP-3 and is taken by proteins like ALP and Vam3p 
(Yeo, 2003). A plasmid expressing ALP-GFP was introduced into WT (BY4741) and 
ncr1Δ (Y02822) strains. In both cases, ALP-GFP was found almost exclusively on the 
vacuolar membrane (Figure 3.7). 
The retrograde transport of endocytosed 14C sucrose and multifunctional receptor 
(MPR) was affected in cultured mammalian NPC1 cells (Neufeld et al., 1999; 
Kobayashi et al., 1999). Vps10p in yeast functions in a similar way to MPR in 
mammalian cells and normally cycles between the Golgi and PVC. If protein 
transport out of the PVC is blocked or delayed, a portion of Vps10p will reach the 
vacuole and undergo proteolytic cleavage (Bilodeau et al., 2002). Vps10p was not 
cleaved only in ncr1Δ strains, indicating normal endosome to Golgi recycling in 
ncr1Δ mutant cells. 
In addition, no obvious changes in sterol homeostasis were detected in ncr1Δ 
cells. It has been shown recently that deletion of NCR1 had no effect on sterol 
synthesis, esterification and uptake and that a mutant form of NCR1 gave rise to 
defects in cellular sphingolipid homeostasis (Malathi et al., 2004). 
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So far, no sterol homeostasis phenotype has been reported as a result of the loss 
of NCR1. It is possible that redundancy, e.g. that parallel pathway(s) exist. 
Alternatively, the function of Ncr1p might not be needed under laboratory growth 
conditions. The yeast vacuole resides at the end of the endocytic pathway and 
contains a variety of hydrolases. Serving primarily as a digestive compartment, the 
vacuole stores and recycles small molecules (Thumm, 2000). It is possible that Ncr1p 
functions as a transporter to facilitate exchange of as yet unknown substrate molecules 
across the vacuole membrane and this role is perhaps only important under certain 
environmental stresses. In this connection, recent studies in higher organisms have 
suggested that Patched and Dispatched, two sterol sensing domain-containing proteins, 
play a role in the cross-membrane transport of yet to be identified molecules (Ma et 
al., 2002). A future aim is to test possible transporter activity of Ncr1p and to identify 
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Chapter 4 Functional Studies on Ncr1p  
 
4.1 Introduction 
Despite intensive investigations, the precise function of NPC1 in intracellular lipid 
transport and in the pathogenesis of NP-C still remains to be elucidated. In particular, 
it is not clear whether NPC1 acts directly on lipid transport or on endocytic trafficking 
events, since both are affected when NPC1 function is lost (Neufeld, 1999; Kobayashi, 
1999). Ko et al. (2001) provided evidence that NPC1 promotes the creation and/or 
movement of a subset of late endosomes; other groups claim that the effect of NPC1 
mutations on endosomal movement is indirect and caused by cholesterol 
accumulation (Zhang, 2001; Lebrand, 2002).  On the other hand, if NPC1 does 
function as a cross-membrane lipid transporter, it is not clear which lipid species, e.g. 
sterols, sphingolipids or fatty acids, serve as the cargo under physiological conditions 
(Davies, 2000; Malathi, 2004). 
In the previous chapter it has been shown that Ncr1p is localized to the vacuolar 
membrane in budding yeast, a counterpart organelle of the lysosome in mammalian 
cells. In this chapter the function of Ncr1p has been explored. 
In mammalian cells, significant cholesterol accumulation in NPC cells occurs 
after feeding exogenous cholesterol or LDL. It is quite interesting to understand the 
function of its ortholog, Ncr1p in budding yeast, which lacks counditious lipoprotein 
receptor and does not take up exogenous ergosterol under aerobic growth conditions 
(Andreasen and Stier, 1953). Our previous results showed that Ncr1p is not involved 
in endocytosis in yeast, including fluid phase and receptor-mediated endocytosis, 
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biosynthetic delivery to the vacuole, retrograde transport from endosome to Golgi and 
ubiquitin- and nonubiquitin-dependent multivesicular body sorting. Recently it was 
shown that deletion of Ncr1p has no effect on sterol synthesis, esterification and 
uptake (Sturley, 2000). However, a mutant form of Ncr1p gave rise to defects in 
cellular sphingolipid homeostasis (Malathi et al., 2004). As for its mammalian 
counterpart, the biochemical function of the native Ncr1p protein in yeast remains to 
be defined.  
In this chapter, we have performed experiments designed to understand the role of 
Ncr1p on ergosterol homeostasis and ergosterol transport. In addition we also 
explored if a synergistic effect between Ncr1p and other ergosterol homeostasis 
related proteins exists under normal culture conditions. 
 
4.2 Results 
4.2.1 The Effect of Ncr1p on Ergosterol Homeostasis 
The prominent phenotype of NPC1 cells is accumulation of cholesterol in the 
endosome/lysosome system. Due to the high homology between Ncr1p and NPC1, it 
is possible that Ncr1p may be involved in sterol transport from the vacuole to other 
organelles. 
The effects of Ncr1p on ergosterol homeostasis are summerized in Figure4.1. 
Each experiment was done from threebiological replicates and each sample is 
triplicated. 
At first, the in vivo ACAT activity was examined in ncr1Δ and WT strains by a 









































































                                                                                   - 125 - 
Figure 4.1 The effect of Ncr1p on sterol homeostasis. A) [3H] incorporation to test the sterol 
esterification rate in WT and ncr1Δ. B) [14C] acetate incorporation to test the sterol 
biosynthesis in WT and ncr1Δ. [14C] which is incorporated into phospholipids was used as 
internal standard. C) Free ergosterol in WT and ncr1Δ at log phase tested by GC-MS. D) 
Total ergosterol (free ergosterol and ergosteryl ester) in WT and ncr1Δ cells was tested by 
GC-MS. E) [3H] incorporation to compare the rate of sterol esterification between the 
control and the strain overexpressing Ncr1p under ADH promotor. F) [14C] acetate 
incorporation to compare the rate of sterol biosynthesis between the control and Ncr1p 
overexpressing strain. G) Compares total ergosterol levels between control and Ncr1p 
overexpressing strains. H) WT and ncr1Δ cells were labeled by [14C] in sterols and 
phospholipids. The vacuoles were extracted and analyzed for their lipids content. The 
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[3H] incorporation assay. [3H] labeled oleate was used as a substrate for ergosterol 
esterification. During the extraction process, [14C]-cholesterol was added as an 
internal standard. The rate of ergosterol esterification was normalized to the cell dry 
weight and internal standard. The average readings of both the WT and ncr1Δ are 
about 1500cpm/mg dried cell weight (Figure 4.1A). These results indicate that the 
NCR1 deletion alone did not affect ergosterol esterification under normal culture 
conditions. 
Using [14C] labeled acetic acid as a substrate, radioactivity incorporated into 
ergosterol was counted in both WT and ncr1Δ to reflect the rate of ergosterol 
biosynthesis. Labelled phospholipids were used as internal standard. The ratio of 
ergosterol to phospholipids in WT was about 0.07 and about 0.05 in ncr1Δ (Figure 
4.1 B). This difference was found to be not significant. 
Free and total ergosterol in cells at log phase were quantitatively analyzed by 
GC-MS. Free ergosterol in the WT strain was about 8mg/g cell dry weight (Figure 
4.1C). Free ergosterol in the ncr1Δ strain was about 7.5mg/g cell dry weight. The total 
ergosterol in both WT and ncr1Δ strains was about 9mg ergosterol/g cell dry weight 
(Figure 4.1D). This shows that deletion of NCR1 alone does not appear to affect the 
total ergosterol levels under standard laboratory conditions. 
Similar experiments were performed in an Ncr1p overexpressing strain. The 
radioactivity counts of [3H] incorporation in pADNS and NCR1-pADNS 
transformants were about 200 and 190cpm/g dried cells, respectively (Figure 4.1E). 
The ratio of ergosterol biosynthesis to phospholipids in pRS426 and NCR1-pRS426 
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transformants was about 0.05 and 0.06, respectively (Figure 4.1F). The total 
ergosterol (free and esterified ergosterol) in pADNS and NCR1-pADNS 
transformants was about 25µg/mg of dried cells (Figure 4.1G). These results indicate 
no significant change in ergosterol homeostasis in ncr1Δ and Ncr1p overexpressing 
strains under standard laboratory culture conditions. 
In order to determine the effect of Ncr1p on the ergosterol composition of the 
vacuole, cells were cultured in YPD at 30ºC and labelled to steady state with 
[14C]-acetic acid. The vacuoles of wild type and ncr1Δ were extracted by the methods 
as mentioned in chapter 2. After extracting lipids from vacuolar fractions and 
separating them by thin layer chromography (TLC), the radioactivities of ergosterol 
and phospholipids were counted. The ratios of ergosterol to phospholipids in both 
strains were about 0.7 (Figure 4.1H). These results show that deletion of NCR1 alone 
may not affect ergosterol distribution in organelles, especially the vacuole, under 
standard laboratory growth conditions. 
 
4.2.2 Two Yeast Orthologs of Insigs, Nsg1p and Nsg2p 
Various reports show that in mammalian cells the Insigs can bind the sterol 
sensing domain of SCAP (Yang et al., 2002; Yabe et al., 2002; Sever et al., 2003). 
Based on sequence homology, two orthologous proteins may exist in yeast, termed 
Nsg1p and Nsg2p. Figure 4.2 shows the alignment of Insigs and yeast Nsgs. The 
amino acid sequences of S. cerevisiae Nsg1p and Nsg2p are 35% identical and 54% 
similar to Insig. 
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Figure 4.2 Alignment of Insigs and Nsgs. Insig1, Insig2, Nsg1p and Nsg2p sequences 
were analyzed by a software, VNTi (Invitrogen, Inc, CA, USA). This calculation was 
excuted by multi-alignment. Red letters on the yellow background represent highly 
conserved amino acids. 
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4.2.3 The Localization of Nsgs-GFP 
In order to study their localization, NSG1 and NSG2 were amplified by PCR and 
fused with the GFP gene on an plasmid. The gene products were expressed in nsg1∆ 
and nsg2∆ cells, respectively. These cells were fixed with formaldehyde, stained with 
the nucleus-specific dye, DAPI, and observed under the fluorescence microscope. The 
results are shown in Figure 4.3.  
The green fluorescence of GFP showed the same localization pattern for both the 
Nsg1p-GFP and Nsg2p-GFP. Two separate parts with strong green light were found in 
these cells. The one was concentrated on the periplasmic membrane and the other was 
on one internal circular membrane. Compared with the blue light from DAPI staining, 
the internal circular membrane was around the nucleus. This periplasmic and 
perinuclear distribution pattern indicates that both Nsg1p-GFP and Nsg2p-GFP are 
located to the ER membrane. The localizations of Nsg1p-GFP and Nsg2p-GFP in 
yeast are consistent with the localization of their homologs in mammalian cells (Yabe 
et al., 2002; Yang et al., 2002). The similarity of their localization patterns implies that 
they also may share a similar function.  
 
4.2.4 Interaction Between Nsgs and Hmg2p-GFP 
A fragment of the HMG2 gene was fused with the GFP gene. Under the 
fluorescence microscope, Hmg2-GFP was observed around the nucleus and close to 
the PM (data not shown).  
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Nsg2p-GFP in Y02956 (nsg2△)





Figure 4.3 The localization of Nsg1-GFP and Nsg2-GFP. NSG1 and NSG2 were 
cloned and fused with GFP. Cells with NSGs-GFP genes were grown to log phase 
and fixed by formaldehyde. The nuclei were stained with DAPI to compare with the 
location of ER. Scale bar, 5µm. 
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As known, Insig1p interacts with the sterol sensing domain of SCAP (Yang T., 
2002) and HMG-CoA reductase (Sever N., 2003). Hence it was supposed that Nsg1p 
and Nsg2p may also interact with HMG-CoA reductase in yeast, Hmg2p. In order to 
check if there was interaction between NSGs and Hmg2, the plasmids harboring 
NSGs and GST-fusion genes were transformed into yeast strains containing 
Hmg2-GFP. After GST pull-down, the beads were washed at least 5 times and 
separated by SDS-PAGE. Figure 4.4 shows the results of in vitro interactions by 
Western blotting analysis after co-immunoprecipitation. In lane 2, there were four 
significant bands which are non specific. In lane 1, the molecular weight of the 
significant band pointed by the arrow was about 150KD, which corresponds to 
Hmg2-GFP. The other bands are non-specific. The patterns in lane 3 and lane 4 were 
similar to the patterns of Nsg1 and its negative control. This result indicates that both 
Nsg1 and Nsg2 can interact with Hmg2 in vitro. This observation is consistent with 
their mammalian homologs (Sever, 2003). 
 
4.2.5 Interaction between Ncr1p and Nsgs 
As shown, Nsg proteins can interact with Hmg2-GFP. Like SCAP and HMG CoA 
reductase, NPC1, which is supposed to function as cholesterol transporter, has a 
conserved SSD. The SSD is also conserved in the S. cerevisiae ortholog, Ncr1p. 
Consequently, the question arose whether Nsg1p or Nsg2p also interact with Ncr1p. 
In order to answer this question, at first, NCR1 was cloned and fused with GFP. NSG1 
and NSG2 were fused with GST as baits. The Ncr1-GFP and Nsgs-GST were mixed 
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Hmg2p-GFP
1    2     3    4
1   2    3    4     5
Figure 4.4 in vitro physical interaction between Hmg2p and Nsgs. Hmg2-GFP and 
Nsgs-GST were expressed in the same strain. GST beads were used to pull down 
Nsgs-GST. Pull down samples were detected by Western blot after separation by 
SDS-PAGE, using anti-GFP antibody. The samples were loaded as follows:  lane1. 
Nsg1-GST + Hmg2p-GFP, lane2. GST + Hmg2p-GFP, lane3. Nsg2-GST + Hmg2p-GFP 
and lane4. GST + Hmg2p-GFP. 
 
Figure 4.5 in vitro physical interaction between Ncr1p and Nsgs. Ncr1-GFP and 
Nsgs-GST were expressed in different strains. The total cell lysates  from both were 
mixed together and GST beads were used to pull down Nsgs-GST. Samples were 
detected by Western blot using anti-GFP antibody. The samples were loaded as follows: 
lane1. Nsg1-GST+Ncr1-GFP, lane2. GST+Ncr1-GFP, lane3. Nsg2-GST+Ncr1-GFP, 
lane4. GST+Ncr1-GFP and lane5. Ncr1-GFP was used as positive control. 
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and GST beads were used for the pull-down. The samples were analyzed by Western 
blot using anti-GFP antibodies. The results are shown in Figure 4.5. 
There was no band in lane 2 and 4, which are the negative controls. In lane 1 and 
3, also no band was detected by anti-GFP antibody. These data indicate that neither 
Nsg1p nor Nsg2p may interact with Ncr1p.  
 
4.2.6 The Role of Ncr1p in the Unfolded Protein Response (UPR) Incluced by 
overloaded sterol  
According to Feng (2003), cholesterol loaded ER can induce the UPR and NPC1 
mutations can reduce the UPR. are1Δare2Δ (unpublished data, Yang) and arv1Δ 
(Tinkelenberg, 2000) have been shown to accumulate free ergosterol in ER. In order 
to analyze whether the deletion of two ergosterol esterification enzymes or ergosterol 
transporter cause UPR in yeast, an UPR reporter constuct was transformed into WT 
and are1Δare2Δ and arv1Δ strains. This pMCZ-Y reporter plasmid contains a lacZ 
gene, which is controlled by the CYC1 promotor and unfolded protein response 
element (UPRE). The results of there assays are as shown in Figure 4.6 A and B.  
The β-galactosidase activiy in are1Δare2Δ was 5 times higher as compared to WT. 
Obviously, UPR occurred in the double deletion cells whose ergosterol homeostasis 
was severely impaired. In arv1Δ cells, the β-galactosidase activity was 300 units, 
compared to 25 in WT were only about 25, as compare to 300 units in. This shows 
that deletion of Arv1 also causes a very strong UPR. These results confirm that 
overloaded sterol induced by are1Δare2Δ or arv1Δ may activate the UPR.  
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Figure 4.6 β-galactosidase assay to test the effect of NCR1 deletion on UPR caused by 
sterol accumulation in the ER. A) β-galactosidase assay to test UPR in are1Δare2Δ. B) 
β-galactosidase assay to test UPR in arv1Δ. C) β-galactosidase assay to test the effect of 
NCR1 deletion on UPR caused by are1Δare2Δ. D) β-galactosidase assay to test the 
effect of NCR1 deletion on UPR caused by arv1Δ. 
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In order to examine whether ncr1Δ has synergic effects with are1Δare2Δ and 
arv1Δ, the NCR1 gene was deleted in these strains as described in Materials and 
Methods. The results of the UPR assay are as shown in Figure 4.6 C and D. The 
β-galactosidase units of WT, are1Δare2Δ and are1Δare2Δncr1Δ were about 100, 325 
and 225, respectively, demonstrating a strong UPR increased in are1Δare2Δ. However, 
deletion of NCR1 in the are1Δare2Δ mutant strain partially reduced the UPR. These 
results suggest that the are1Δare2Δ deletions cause accumulation of ergosterol in the 
ER membrane, which may be derived from de novo ergosterol and ergosterol 
transported from other organelles. Finally, the mutations lead to changes in ergosterol 
distribution and metabolism. This indicates that possibly Ncr1p facilitates the 
transportation of ergosterol from the vacuole to the ER. When NCR1 is deleted, part 
of ergosterol is sequested in the vacuole and the total amount of ergosterol 
accumulating in the ER decreases. However, at the same time, ergosterol from other 
sources is still imported into the ER. Therefore, the free ergosterol stress in the ER is 
partially reduced. This may explain why an NCR1 deletion did not decrease the 
β-galactosidase units in are1Δare2Δ to the level in WT. 
Although the mechanism may be different, deletion of ARV1 also causes 
significant UPR. The activities of β-galactosidase in WT, arv1Δ and arv1Δncr1Δ were 
about 100, 250 and 130 units, respectively. These results also show that deletion of 
NCR1 can partially inhibit UPR caused by arv1Δ. Tinkelenberg (2000) showed that 
Arv1p is localized to the ER membrane. It is believed to catalyze ergosterol efflux 
from ER.  
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 4.3 Disscusion 
Based on the data from previous research, Ncr1p may be an ergosterol transporter. 
Thus, ergosterol esterification, biosynthesis and total ergosterol were compared 
between ncr1Δ and wild type cells. Our results showed that there was no significant 
differencein those parameters. These results are consistent with the observation of 
Sturley (2000). In addition, unlike NPC cells, no apparent ergosterol accumulation 
was found in vacuoles of ncr1Δ cells. One explanation may be that other redundant 
pathways exist. There are various ways for cells to complement defects induced by 
NCR1 deletion or overexpression, which suggests synergistic effects between Ncr1p 
and other proteins. 
For Ncr1p functional studies, it was necessary to look for various phenotypes 
under conditions of more stringently disturbed sterol homeostasis. These conditions 
included inactivation of important protein related sterol homeostasis and harsh culture 
conditions. Initially, the relationship between Ncr1p and other known proteins which 
affect sterol homeostasis were considered.  
In mammalian cells, Insigs regulate proteolytic processing of SREBP (Yang et al., 
2002) and degradation of HMGR (Sever et al., 2003). In both processes, Insigs bind to 
the SSD of SCAP and HMGR. In budding yeast, so far, no similar results have been 
reported. However, we identified two orthologs of INSIGs and named them NSG1 and 
NSG2. Characterization studies showed that both these proteins are localized to the 
ER membrane. These observations are in agreement with their mammalian 
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counterparts. Therefore it was speculated that the conservation of their location may 
also imply the conservation of their function. In INSIGs deletion strains, SREBP is 
constitutively escorted to the Golgi apparatus and promotes ergosterol biosynthesis by 
SCAP, which increases ACAT activity (Richard et al., 2003; Christopher et al., 2004). 
[3H] incorporation assays showed a slight increase of ergosterol esterification in 
nsg2Δ and nsg1Δnsg2Δ cells. Ergosterol esterification in nsg2Δ was slightly lower 
than in nsg1Δnsg2Δ. Interestingly, NSG1 deletion mutant showed even lower 
ergosterol esterification. These results are consistant with the recently published data 
(Flury et al., 2005). In this report, Nsg1p is thought to limit degradation of Hmg2p. 
This phenotype is in conflict with date from mammalian cells. In analogy with other 
protein pairs with similar function in yeast, such as Are1p and Are2p, it is possible 
that Nsg1p may mainly regulate ergosterol biosynthesis and Nsg2p may have some 
other function. Upon Nsg1p loss of function, Nsg2p can complement this loss. 
In order to understand the effect of Nsgs on ergosterol metabolism, total ergosterol 
was determined in the WT and mutant strains. The results showed that there was no 
difference between them. A possible explanation is that changes in ergosterol 
biosynthesis are rapidly compensated by the other processes contributing to ergosterol 
homeostasis. 
Because Insigs interact with SCAP and HMG-CoA reductase to regulate 
cholesterol biosynthesis, we assumed that Nsgs may also interact with the orthologs 
of SCAP and HMG-CoA reductase in S. cerevisiae. However, we could not identify 
any ortholog of SCAP in S. cerevisae. These findings indicate that the regulatory 
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mechanism of ergosterol homeostasis in S. cerevisiae may be different from that of 
cholesterol in mammalian cells. The ortholog of HMG-CoA reductase in S. cerevisiae  
is Hmg2p. Our results show that both Nsg1p and Nsg2p can indeed interact with the 
yeast HMGR ortholog, Hmg2. This property of yeast Nsgs is consistant with that of 
mamalian Insigs (Sever et al., 2003). Therefore, we hypothesized that Nsgs may 
interact with the SSD of Ncr1p. By in vitro immuno-precipitation assay no physical 
interaction between Ncr1p and Nsgs was detected. Because Ncr1p is mainly localized 
to the vacuolor membrane at steady state and Nsg1p and Nsg2p are on the ER 
membrane, the result is consistent with the localization data. This suggests that the 
regulation of Ncr1p function may be controlled by a different mechanism. 
Other important proteins affecting ergosterol homeostasis are Are1p, Are2p and 
Arv1p (Tinkelenberg, 2000). Deletion of ARV1 alters ergosterol distribution. 
Abnormal function of these genes leads to severe impairment of ergosterol 
homeostasis. Our results showed that deletion of both ARE1 and ARE2 or ARV1 alone 
caused enhanced reporter gene expression, which is regulated by the unfolded protein 
response element (UPRE). Accumulation of ergosterol in cells, especially in the ER, 
leads to apparent ER stress which in turn stimulates the unfolded protein response 
(UPR).  
Oxidative stress, Ca2+ disturbance and hypoxia can induce the UPR. Free 
cholesterol loading in the ER is also a factor to cause UPR. These factors can activate 
some ER located protein kinases, including Ire1, PERK and ATF6. The N-termini of 
these kinases bind the chaperone, Grp78, under normal conditions which inactivates 
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them. When unfolded proteins increase, Grp78 binds to them and dissociate off the 
ER transmembrane protein kinase, thus causing Ire1 and PERK to oligomerize. The 
conformational change of Ire1 activates the intrinsic ribonuclease activity, which is 
involved in mRNA processing of transcription factor, X box protein-1 (XBP-1). This 
in turn induces expression of a series of genes involved in restoring protein 
conformation and degradation of misfolded proteins. Oligomerized PERK 
phosphorylates and inactivates the mRNA translation initiation factor, eIF2α. This 
inhibits the synthesis of most proteins, except selected proteins which restore ER 
function, such as ATF4. The free ATF6 is translocated to the Golgi complex for 
proteolysis to produce active ATF6. Finally, the active form is translocated to the 
nucleus to control specific UPR gene expression. Under more severe ER stress 
conditions, the other effect of Ire1 is to trigger programmed cell death, mainly 
apoptosis. The mechanism still remains to be elucidated. 
In mammalian cells, the ER was shown to be the site of cholesterol-induced 
cytotoxicity (Feng et al., 2003). Both U18666A, a drug inhibiting cholesterol 
trafficking from late endosomes to the ER, or NPC1 deletion protect cells from 
apoptosis caused by UPR. This phenomenon demonstrates the importance of 
cholesterol homeostasis. 
Are1p and Are2p esterify excess ergosterol to ergosteryl esters. Ergosteryl esters 
are non-toxic to cells, hence it is a way to remove excess ergosteryl. Deletion of ARE1 
and ARE2 eliminates almost all cellular activity of ergosterol esterification, thus 
blocking a key pathway to eliminate ergosterol from the ER. It is possible that large 
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amounts of free ergosterol accumulate in the ER in the ARE1 and ARE2 double 
deletion strain. This may explain why lack of the functional ergosterol esterification 
enzymes causes extensive UPR. 
Arv1p is localized to the ER membrane. Some evidence indicates that it may play 
an important function in ergosterol efflux from the ER. Interestingly, arv1 and are2 
single mutants are viable, but deletion of both genes is lethal. This observation is 
comparable with the cell death in mammalian cells under cholesterol-loading 
conditions. Deletion of both ARV1 and ARE2 might block the main efflux of 
ergosterol from the ER. At least 70% of cellular ergosterol are esterified to neutral 
lipids by Are2p, which seems to be more specific than Are1p. Both ARE2 and ARV1 
single deletions may cause ergosterol accumulation in the ER, but the cells are still 
viable. However, when ARE2 and ARV1 are disrupted together, ergosterol 
accumulates excessively in the ER and causes severe physiological changes. Hence, 
ARV1 and ARE2 double deletions are lethal and may be functioning synergistically.  
The cells with single NCR1, ARE1, ARE2 and ARV1 deletions are viable. 
Considering Ncr1p to be an ergosterol transporter or at least involved in ergosterol 
efflux from the vacuole, we were interested to know if Ncr1p synergistically functions 
with Arv1p, Are1p and Are2p. UPR assays showed that both are1∆are2∆ncr1∆ and 
arv1∆ncr1∆ reduce the intensity of UPR, compared to are1∆are2∆ and arv1∆,. These 
results implicate that deleting NCR1 may cause less ergosterol accumulation in the ER. 
Based on the localization of Ncr1p, Arv1p and Are1p, it is possible that loss of Ncr1p 
affects transport of ergosterol from the vacuole to the ER, which in turn reduces 
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ergosterol-induced ER stress. These results confirm our hypothesis that Ncr1p 
functions synergistically with Are1p, Are2p and Arv1p. 
In the next chapter, we will discuss the relationship between Ncr1p and other 
ergosterol homeostasis related proteins under stringent culture conditions. The 
stringent conditions may amplify the differences between WT and mutant strains. The 
relationship between different genes probably would allow us to understand the 
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Chapter 5 Role of Ncr1p in Subcellular Sterol Transport in 
Saccharomyces cerevisiae 
5.1 Introduction 
Niemann Pick Disease type C (NPC) is an autosomal recessive, neurovisceral 
lipid storage disorder (Paterson et al., 2001). This disease is characterized by the 
accumulation of free cholesterol and glycosphingolipids within the 
endosomal/lysosomal system in various cell types including neurons. Over 95% of 
NPC cases are caused by mutations in the NPC1 gene, which was identified in 1997 
by a positional cloning approach (Carstea et al., 1997). The human NPC1 coding 
sequence predicts an integral membrane protein of 1,278 amino acids with a few 
important structural features, including an NPC domain near its amino-terminus that 
is conserved in all NPC1 orthologs, and a putative sterol sensing domain (SSD), 
which can be found in key proteins governing cellular sterol homeostasis (Brown and 
Goldstein, 1999). The NPC1 protein predominantly localizes to late endosomes, and 
transiently associates with lysosomes and the trans-Golgi network (Higgins et al., 
1999; Zhang et al., 2000). It is believed that the NPC1 protein modulates the transport 
of lipids in the endosomal system. However, despite years of intensive research, the 
molecular function of NPC1 remains elusive. For instance, it is not clear how exactly 
NPC1 controls the movement of lipids at endosomal membranes; further, it remains 
controversial which lipid species, e.g. sterols, sphingolipids or fatty acids, may serve 
as the primary substrate for NPC1 under physiological conditions (Davies et al., 2000; 
Malathi et al., 2004).  
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The yeast Saccharomyces cerevisiae is a simple but powerful model system and 
has proven to be an invaluable tool in the investigation of cellular sterol and lipid 
metabolism (Sturley, 2000). A homologous open reading frame (ORF) to human 
NPC1 (~40% identity, ~75% similarity at protein level) was identified in yeast and 
named NCR1 (for NPC1 related gene 1) (Malathi et al., 2004; Sturley, 2000). Ncr1p 
has several predicted structural features that are strikingly similar to those of NPC1, 
including a putative sterol-sensing domain. Surprisingly, deletion of NCR1 had no 
obvious effect on sterol synthesis, esterification and uptake at steady state. Moreover, 
a mutant form of NCR1 caused redistribution of plasma membrane sphingolipids but 
did not affect sterol metabolism (Malathi et al., 2004). It was, therefore, proposed that 
the primordial function of Ncr1p and its mammalian counterparts is to modulate 
sphingolipid recycling (Malathi et al., 2004). 
Our previous work demonstrated that Ncr1p localizes to yeast vacuole membrane 
through the vacuolar protein sorting pathway (Zhang et al., 2004). The yeast vacuole 
resides at the end of the endocytic pathway and contains a variety of hydrolases. 
Serving primarily as a digestive compartment, the vacuole stores and recycles small 
molecules, especially under certain environmental stresses (Thumm, 2000). We 
hypothesized that Ncr1p could function as a transporter to facilitate exchange of small 
molecules, such as sterols, across the limiting membrane of the vacuole and that this 
role was perhaps not needed under standard laboratory conditions. 
In this study, we sought conditions that can trigger sterol movement between 
cellular organelles in budding yeast. We then examined the role of Ncr1p in sterol 
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trafficking under these conditions. We provide convincing evidence that under acute 
glucose starvation, sterol transport out of the vacuole is compromised when the NCR1 
gene is deleted. 
 
5.2 Results 
5.2.1 Acute Glucose Starvation Induces Increase a Sterol Esterification. 
Mammalian cells acquire cholesterol through exogenous uptake (mainly from 
low density lipoprotein uptake) and endogenous synthesis. The biochemical hallmark 
of NPC1 mutant cells is the accumulation of low density lipoprotein (LDL) derived 
cholesterol in the endosomal/lysosomal system. Recent studies suggested that the 
transport of endogenously synthesized cholesterol is also partially defective in mutant 
NPC1 cells (Cruz and Chang, 2000; Reid et al., 2003). However, based on reports by 
Malathi et al. (2004) and our previous data, no changes in sterol homeostasis have 
been detected in ncr1Δ cells despite the striking evolutionary conservation between 
NCR1 and NPC1. This could be explained by the fact that the budding yeast does not 
take up sterol from its external environment during aerobic growth. Alternatively, the 
apparent normal sterol metabolism in ncr1Δ strain might result from a lack of 
movement of endogenous sterol between subcellular organelles, especially movement 
into and out of the vacuole, under laboratory growth conditions. To address the latter 
possibility, we searched for conditions under which there is a sharp increase in sterol 
esterification activity. In mammalian cells and yeast, sterol esterification takes place 
in the ER. The extent of sterol esterification is thought to reflect the regulatory pool of 
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ER sterol and has been widely used as a standard method for monitoring sterol 
transport to the ER (Lange and Steck, 1997; Debry et al., 1997).  
We tested a variety of conditions in order to find one under which there are 
drastic changes in sterol esterification in a yeast wild type (WT) strain: SCY062. To 
this end, acute glucose starvation, i.e. changing growth medium from YPD to YP, 
induced a 4-5 fold increase in the rate of oleate incorporation into steryl esters in WT 
cells (Figure 5.1). Surprisingly, there was little change in oleate incorporation into 
triglycerides (TG) under this condition. This result is largely in agreement with a 
previous study which reported that there was a sharp increase in the rate of sterol 
esterification upon entry of yeast cells into the stationary growth phase due to nutrient 
starvation (Bailey and Parks, 1975). The increase in sterol esterification suggests that 
sterols of yet to be identified sources are moving back to the ER upon glucose 
withdrawal. To determine the role of Ncr1p in this form of sterol transport, ncr1Δ 
(SZY001) cells were subjected to acute glucose starvation. However, there was no 
significant difference in the rate of oleate incorporation between WT and ncr1Δ 
strains under such experimental conditions (Figure 5.1).  
 
5.2.2 Deletion of NCR1 Decreases Sterol Eesterification in are2Δ but not in are1Δ 
Mutant Cells During Acute Glucose Starvation. 
There are two sterol esterification enzymes in S. cerevisiae, Are1p and Are2p, 
and both of them have been shown to localize to the ER (Yang et al., 1997; Zweytick 
et.al, 2000). It has recently been shown that sterol esterification is required for sterol 















































Figure 5.1 Acute glucose starvation stimulates sterol esterification. WT (SCY062) and 
ncr1Δ (SZY001) cells were grown to mid-log phase in YPD, washed and then cultured 
in YP containing [3H] oleate for 30 minutes. The rate of oleate incorporation into sterol 
esters (SE) and triglycerides (TG) was measured as described in Materials and Methods.
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uptake and, possibly, transport (Li and Prinz, 2004). We wondered whether Ncr1p is 
functionally linked to individual sterol esterification enzymes, i.e. Are1p or Are2p. 
Thus, we examined and compared sterol esterification in are1Δ (SCY060) and 
are1Δncr1Δ (SZY002); are2Δ (SCY061) and are2Δncr1Δ (SZY003) strains upon 
acute glucose starvation. Cells were grown to mid-log phase in YPD, washed and 
resuspended in YP containing [3H] oleate for 30 minutes. As in the wild type cells, 
acute glucose starvation induced a 4-5 fold increase in the rate of oleate incorporation 
into steryl esters in are1Δ and are2Δ cells (Figure 5.2). Whereas there was little 
difference in sterol esterification between are1Δ and are1Δncr1Δ cells, a nearly 40% 
decrease was observed in the are2Δncr1Δ strain when compared with the are2Δ strain 
(Figure 5.2B). As a control, oleate incorporated into TG at similar rates among all 
strains, suggesting there is no defect in fatty acid transport to the ER. These results 
suggest that, among other possibilities, Ncr1p delivers sterol to the sites of Are1p for 
esterification. Lastly, similar results were obtained by three different individual 
researchers in our laboratory and by using a yeast strain with a different genetic 
background (data not shown). 
 
5.2.3 The Effect of ncr1Δ Deletion During Acute Glucose Starvation is Time 
Dependant. 
To obtain kinetic features of oleate incorporation after glucose withdrawal, time 
course experiments were performed. After shifting to YP at 0 min, 60 min and 120 
min, different strains were pulsed with [3H] oleate for 30 min. The rate of sterol 



































































































Figure 5.2 The activation of sterol esterfication in are2Δ, but not that in are1Δ, is partially 
inhibited by the deletion of NCR1. In vivo oleate incorporation into SE and TG was 
measured in four strains: are1Δ (SCY060), are1Δncr1Δ (SZY002) (A); are2Δ (SCY061), 
are2Δncr1Δ (SZY003) (B). The experimental procedure was exactly the same as 
described in Figure5.1. (*, p<0.01). 
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esterification was highest at 0 min in YP (Figure 5.3). The difference in sterol 
esterification between are2Δ and are2Δncr1Δ was obvious when labeled at 0 min 
(Figure 5.3C), but disappeared at later time points. These data suggest that there is a 
delay, but not a complete block in sterol movement to the ER in the are2Δncr1Δ 
strain. 
 
5.2.4 The Enzyme Activity of Are2p does not Change Upon Glucose Withdrawal. 
To rule out the possibility that deletion of NCR1 directly affects the intrinsic 
enzymatic activity of Are2p, sterol esterification was measured in vitro. Cells were 
grown exactly the same way as in the in vivo oleate incorporation experiment. After 
shifting to YP for thirty minutes, cells were lysed and microsomal fractions were 
isolated. Cold cholesterol and [14C] oleoyl-CoA were added as the substrates. As 
shown in Figure 5.4, the microsomal fractions from are2Δ and are2Δncr1Δ strains 
exhibited similar rates of sterol esterfication, indicating no difference in the capacity 
of Are1p in sterol esterification upon deletion of NCR1. Interestingly, the sterol 
esterification activity from each strain was not disturbed by glucose withdrawal, 
which is in stark contrast to the in vivo measurements. This indicates that glucose 
withdrawal did not change the kinetic properties of the enzymes, but rather, it induced 
the ER relocation of sterols.  
 
5.2.5 Free Sterol is Accumulated in the Vacuole of are2Δncr1Δ and 
are1Δare2Δncr1Δ. 


























































































































































Figure 5.3 Kinetic analysis of sterol esterification activity upon glucose starvation. In vivo
oleate incorporation into SE and TG was measured in six strains (defined in Figures5.1 
and 2): WT and ncr1Δ (A); are1Δ and are1Δncr1Δ (B); are2Δ and are2Δncr1Δ (C). [3H] 
oleate was added at 0min, 60min and 120min after changing media to YP and all strains 
were pulsed for 30 minutes. Lipids were extracted and analyzed as described in Materials 
and Methods. (*, p<0.01). 
 
 



















































Figure 5.4 In vitro (microsomal) assay of sterol esterification. WT, are2Δ and are2Δncr1Δ
strains as described in Figure5.2 were grown to mid-log phase in YPD, washed, cultured in 
YP for 30 minutes and harvested. Microsomes were isolated and used to assay cholesterol 
esterification in vitro. [14C]oleoyl-CoA (20nmol) and cold cholesterol were used as 
substrates. In A, 2μg cold cholesterol was added and in B, 20μg cold cholesterol was used. 
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To verify whether free ergosterol accumulates in the vacuoles of ncr1Δ mutants 
under the experimental conditions employed above, vacuoles were purified after 30 
minutes of glucose withdrawal using a well established method (Haas, 1995). Lipids 
were extracted, separated by TLC and free ergosterol was quantified by a scanning 
method (Sorger et al., 2004). As shown in Figures 5.5A and B, no significant 
difference in the level of vacuolar ergosterol was detected between wild type and 
ncr1Δ strains or between are1Δ and are1Δncr1Δ strains. In contrast, a ~50% increase 
in the amount of vacuolar ergosterol was found in the are2Δncr1Δ strain when 
compared with the are2Δ strain (Figure 5.5C). Interestingly, an even bigger 
difference (~60%) in the level of vacuolar free ergosterol was detected between 
are1Δare2Δ and are1Δare2Δncr1Δ strains (Figure 5.5D).  
 
5.3 Discussion 
Sterol esterification and sterol transport are closely related cellular processes. It 
has been known for a long time that defects in sterol transport affect the efficiency of 
sterol esterification (Pentchev et al., 1985). However, the impact of sterol 
esterification on sterol transport has not been studied yet. Therefore, in the present 
studies we investigated the functional relationship between sterol esterification 
enzymes (Are1p and Are2p) and a putative sterol transport protein (Ncr1p) in budding 
yeast. Our data show that subcellular sterol transport upon glucose withdrawal was 
indeed affected when the NCR1 gene was deleted. However, this defect was 
detectable only when either the major sterol esterification enzyme (Are2p) or both 



































































































Figure 5.5 Quantification of vacuolar free sterol. Isogenic yeast strains with the indicated 
genotypes (are1Δare2Δ, SCY059; are1Δare2Δncr1Δ, SZY004; the identities of other strains 
are as described in Figures5.1 and 2) were grown to mid-log phase in YPD, washed twice with 
water and incubated for another 30min in YP. Cells were lysed and vacuoles purified. Lipids 
were extracted, separated by TLC and free ergosterol was quantified by direct densitometry 
scanning at 275nm using a CAMAG TLC Scanner 3. Each experiment was performed in 
triplicates. 
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enzymes (Are1p and Are2p) were deleted. 
It has been shown that the two isoforms of sterol estification enzymes co-exist 
and localize to the same organelle, i.e. ER, in yeast. The physiological role of Are1p 
is probably to esterify sterol precursors during anaerobic growth, whereas Are2p is 
required to efficiently esterify ergosterol during aerobiosis (Zweytick et al., 2000; 
Jensen-Pergakes et al., 2001). Sterols from subcellular organelles including the PM, 
vacuole (including membrane lipids ingested due to autophagy), endosomes etc. move 
back to the ER for esterification upon glucose starvation, most likely using a 
“super-highway” through membrane contact sites (Li and Prinz, 2004; Holthuis and 
Levine, 2005). Conceivably, this non-vesicular transport of sterols may be facilitated 
by sterol esterification, especially the action of Are2p, which is the major ergosterol 
esterification enzyme (Yang et al., 1997). In support of this, a recent study showed 
that sterol esterification was reqired for sterol uptake in yeast and that ER sterol was 
rapidly returned to the plasma membrane if not esterified (Li and Prinz, 2004).  
Thus based on our observations, we hypothesized that in wild type or ncr1Δ cells, 
most sterols move back to the ER for esterification upon glucose starvation in a 
nonvesicular manner, i.e. through membrane contact sites. These sterols are rapidly 
esterified by the sterol esterification enzymes, especially by Are2p. There should be a 
small pool of sterol going into the vacuole in WT cells, possibly by the endocytic 
transport or autophagy (Teter et al., 2001). This pool of ergosterol would be recycled 
and delivered to other sites including the ER for esterification. The release of this pool 
of ergosterol should be delayed in ncr1Δ cells. However, due to technical difficulties, 
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the temporary accumulation of sterol in the vacuole of ncr1Δ cells could not be 
detected neither by measuring oleate incorporation nor by direct quantification of 
vacuole ergosterol. In fact, we often observed a small decrease (~10%) of oleate 
incorporation and a small increase (~10%) of vacuolar ergosterol in ncrΔ cells when 
compared to wild type cells. Based on these small differences no firm conclusions 
could be drawn. Another possible explanation is that the ergosterol transport between 
contact sites may be the major pathway and is in charge of most of the ergosterol 
transport from the PM to the ER. When Ncr1p is inactive, less ergosterol passes 
through the endocytic pathway and is transported through the major pathway.  
In are2Δ cells, we hypothesize that more sterols are diverted to the 
vacuole/Ncr1p pathway since sterols can not be rapidly esterified in the ER, and the 
ER is not capable of keeping a large amount of free ergosterol (Li and Prinz, 2004). 
Indeed, a 2-3 fold increase of vacuolar ergosterol was detected in are2Δ or 
are1Δare2Δ cells upon glucose withdrawal when compared to WT (data not shown). 
Therefore, the vacuolar/Ncr1p pathway becomes more prominent in cells defective in 
sterol esterification and accumulating free ergosterol.  In this respect it should be 
noted that trafficking defects of endogenously synthesized cholesterol were detected 
in various mammalian NPC cells (Reid et al., 2003). However, the most prominent 
defect was detected in NPC macrophages. The authors suggested that macrophages 
may depend more on NPC1 to maintain a high cholesterol-recycling rate. Lastly, 
deletion of ARE1 had no effects on the Ncr1p pathway because sterol esterification 
activity is higher in are1Δ cells than in WT cells (Yang et al., 1996). Based on our 
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data, deductions and hypothesis we propose a model for the mechanism of Ncr1p in 
Figure 5.6.  
It should be noted that the condition used in this study to induce sterol relocation, 
i.e. acute glucose starvation, occurs often in the natural environment and has also been 
widely used in the field of glucose signaling (Gorner et al., 2002; Ashe et al., 2000). 
For instance, a thunderstorm would wash away yeast from grapes, a rich source of 
sugar. The induction of sterol esterification by glucose starvation is most likely 
caused by the reorganization of subcellular sterol distribution but not by an increase in 
endogenous sterol biosynthesis, since it has been demonstrated previously that key 
sterol biosynthetic enzymes are rapidly degraded upon nutrient starvation (Hampton 
et al., 1996). 
In summary, this study provides first and initial insights into the role of Ncr1p in 
sterol transport in yeast. Our results suggest that the Ncr1p function may not be 
needed when cells are grown in rich media. Under more natural conditions, e.g. 
starvation conditions when membrane lipids are taken into the vacuole possibly by 
autophagy, the recycling of sterols by Ncr1p would become essential for cells to 
survive. In fact, it has been reported recently that ncr1Δ cells exhibit apparent severe 
growth defects on minimal media (Dunn B et al., personal communication with the 
Saccharomyces Genome Database). Most importantly, our results strongly suggest 
that the primordial function of the NPC1 protein family is to regulate the endocytic 
movement of sterols, since a delay in sterol transport was detected in the ncr1Δare2Δ 
strain no later than 30 minutes after glucose withdrawal. Recent evidence also points 
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to a direct role of NPC1 in sterol transport. The SSD domains of NPC1 and SCAP 
have been shown to bind cholesterol directly (Ohgami et al., 2004; RadhaKrishnan et 
al., 2004). The next challenge is to identify other protein components of the Ncr1p 
pathway and to understand in molecular detail how these proteins control the exit of 
sterols from the vacuole. In addition, it would be interesting to identify the molecules 
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Chapter 6 Conclusions and Prospects 
 
6.1 Conclusions 
As reviewed in previous chapters, cholesterol is an irreplaceable molecule in 
multicellular animals. This molecule appears to have evolved only in higher animals. 
Cholesterol homeostasis is maintained by regulation of cholesterol synthesis, uptake, 
transport, esterification, utilization, efflux and storage. Among them, cholesterol 
transport maintains a dynamic balance of the cholesterol gradient between different 
organelles. Our studies were aimed at understanding intracellular sterol transport 
using yeast as a model system. In this attempt we try to understand the role of Ncr1p 
in sterol transport.  
Our studies demonstrate that Ncr1p is a ~130 kDa vacuolar membrane protein. 
Consistent with the previous reports on localization, Ncr1p does not exist in raft 
microdomains, which are often present in plasma and Golgi membranes. Ncr1p is 
transported to the vacuole by the VPS pathway. Unlike mammalian lysosomal 
proteins, no signal peptide is involved in Ncr1p transport. At least, deletion of the 11 
C-terminal amino acids did not affect its localization. In consistant with the 
hypothesis that the vacuole and the PM may be the default transportation destination 
of proteins in yeast and mammalian cells, respectively. 
No significant effect on ergosterol homeostasis was observed by either Ncr1p 
deletion or over-expression. To gain further insight into the ergosterol distribution and 
metabolism within the cell, relationship between Ncr1p and other ergosterol 
homeostasis related proteins were studied. 
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Recent research showed that Insigs directly interact with the SSD of HMG-CoA 
and SCAP. Our studies showed that S. cerevisiae Insig orthologs, Nsg1p and Nsg2p, 
can interact with Hmg2p, however, no physical interaction was observed between 
Ncr1p and Nsgs. 
Deletion of NCR1 decreases strongly the UPR stimulated by ARV1 deletion. 
Similar experiment showed that ncr1Δ also decreases the UPR that is activated by 
deletion of are1Δare2Δ. These results confirm our hypothesis that Ncr1p may be 
involved in ergosterol transport from the vacuole to the ER. 
After standardizing various conditions, acute glucose starvation was found to 
increase the rate of ergosterol esterification. Deletion of Ncr1p inhibited the increased 
ergosterol esterification only temporarily (at first 30 minutes). Pulse-chase 
experiments showed that ergosterol may be transported to the ER for esterification. 
Furthermore labelling experiments showed that ergosterol was transported via the 
vacuole and NCR1 deletion caused accumulation of ergosterol in the vacuole. 
However, our experiments indicate that there may be more than one pathway. These 
results are in agreement with the results of Prinz (2002) which demonstrate that at 
least one more pathway exists between the PM and the ER besides the vesicular 
pathway. An additional pathway seems to be in charge of a large proportion of PM 
ergosterol internalization.  
 
6.2 Prospects 
Our studies have helped to understand the role of Ncr1p on ergosterol transport, 
                                                                                   - 163 - 
however, the detailed information on the mechanism of how Ncr1p affects the efflux 
of ergosterol out of the vacuole and how ergosterol is transported from the vacuole to 
the ER still remains to be elucidated. Three interesting questions needs to be answered 
in order to understand the exact mechanism.  
Firstly, which proteins interact with Ncr1p or facilitate ergosterol transport from 
the vacuole to the ER. Both in vivo and in vitro assays can be used to detect the 
proteins that interact with Ncr1p. Once these proteins are identified, their domains 
involved in protein-protein interaction also need to be determined. These proteins will 
further help to understand the mechanism of ergosterol transport from the vacuole to 
the ER. The function of these proteins will be an important clue in the pathway of 
ergosterol transport.  
Secondly, how does ergosterol interact with these proteins? Identification of 
ergosterol binding domains will be helpful in understanding not only the structure of 
these ergosterol transport-related proteins, but also the pattern of ergosterol transport. 
In addition, the regulation of the transport pathway is also a very interesting 
question in the future. Besides protein-protein interacting domains and the 
protein-ergosterol interacting domains, identification of regulatory domains in these 
proteins are also very exciting to understand this dynamic pathway. 
Whether Ncr1p also affects transport of other lipids is another important question. 
These studies may help us to understand the correlation of the different lipids, such as 
ergosterol, sphingolipids and phospholipids. 
In the long-term, we are interested to understand the entire pathway of 
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intracellular ergosterol transport. The organization of this specific molecule in the cell 
is a fascinating part of biology. This will reveal how a cell organizes its chemical 
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